National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)
made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the
National Health Act 1953
Compilation No. 78
Compilation date: 1 April 2019
Includes amendments up to: PB 17 of 2019
Registered: 16 April 2019
This compilation is in 6 volumes
Volume 1: sections 1–26 and Schedule 1 (A–C)
Volume 2: Schedule 1 (D–K)
Volume 3: Schedule 1 (L–P)
Volume 4: Schedule 1 (Q–Z), Schedules 2 and 3
Volume 5: Schedule 4 (Part 1: A–R)
Volume 6: Schedule 4 (Part 1: S–Z, Part 3), Schedule 5 and
Endnotes
Each volume has its own contents
About this compilation
This compilation
This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) that shows the text of the law as amended and in force on 1 April 2019 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
Schedule 1—Ready‑prepared pharmaceutical benefits
Schedule 1—Ready‑prepared pharmaceutical benefits
(sections 5 to 10, 16 to 18, 20, 21, 23 to 26)
Listed Drug | Form | Manner of Administration | Schedule Equivalent | Brand | Responsible Person | Authorised Prescriber | Circumstances | Purposes | Maximum Quantity | Number of Repeats | Pack Quantity | Determined Quantity | Section 100/ Prescriber Bag only |
Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral |
| Pradaxa | BY | MP NP | C4369 C4381 C4402 | P4381 | 20 | 0 | 10 |
|
|
MP NP | C4369 C4381 C4402 | P4369 | 20 | 1 | 10 |
|
| ||||||
MP NP | C4369 C4381 C4402 | P4402 | 60 | 0 | 60 |
|
| ||||||
Capsule 110 mg (as mesilate) | Oral |
| Pradaxa | BY | MP NP | C4269 C4369 C4381 C4402 | P4381 | 20 | 0 | 10 |
|
| |
MP NP | C4269 C4369 C4381 C4402 | P4369 | 20 | 1 | 10 |
|
| ||||||
MP NP | C4269 C4369 C4381 C4402 | P4402 | 60 | 0 | 60 |
|
| ||||||
MP NP | C4269 C4369 C4381 C4402 | P4269 | 60 | 5 | 60 |
|
| ||||||
Capsule 150 mg (as mesilate) | Oral |
| Pradaxa | BY | MP NP | C4269 |
| 60 | 5 | 60 |
|
| |
Dabrafenib | Capsule 50 mg (as mesilate) | Oral |
| Tafinlar | NV | MP | C6013 C6044 | P6044 | 120 | 3 | 120 |
|
|
MP | C6013 C6044 | P6013 | 120 | 5 | 120 |
|
| ||||||
Capsule 75 mg (as mesilate) | Oral |
| Tafinlar | NV | MP | C6013 C6044 | P6044 | 120 | 3 | 120 |
|
| |
MP | C6013 C6044 | P6013 | 120 | 5 | 120 |
|
| ||||||
Daclatasvir | Tablet 30 mg | Oral |
| Daklinza | BQ | MP NP | C5969 C5972 | P5969 | 28 | 2 | 28 |
|
|
MP NP | C5969 C5972 | P5972 | 28 | 5 | 28 |
|
| ||||||
Tablet 60 mg | Oral |
| Daklinza | BQ | MP NP | C5969 C5972 | P5969 | 28 | 2 | 28 |
|
| |
MP NP | C5969 C5972 | P5972 | 28 | 5 | 28 |
|
| ||||||
Dalteparin | Injection containing dalteparin sodium 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP |
|
| 20 | 0 | 10 |
|
|
MP NP |
| P4910 | 20 | 3 | 10 |
|
| ||||||
Injection containing dalteparin sodium 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP |
|
| 20 | 0 | 10 |
|
| |
MP NP |
| P4910 | 20 | 3 | 10 |
|
| ||||||
Injection containing dalteparin sodium 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP |
|
| 10 | 1 | 10 |
|
| |
MP NP |
| P4910 | 20 | 3 | 10 |
|
| ||||||
MP NP |
| P4967 | 30 | 5 | 10 |
|
| ||||||
Injection containing dalteparin sodium 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP |
|
| 10 | 1 | 10 |
|
| |
MP NP |
| P4910 | 20 | 3 | 10 |
|
| ||||||
MP NP |
| P4967 | 30 | 5 | 10 |
|
| ||||||
Injection containing dalteparin sodium 12,500 I.U. (anti-Xa) in 0.5 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP |
|
| 10 | 1 | 10 |
|
| |
MP NP |
| P4910 | 20 | 3 | 10 |
|
| ||||||
MP NP |
| P4967 | 30 | 5 | 10 |
|
| ||||||
Injection containing dalteparin sodium 15,000 I.U. (anti-Xa) in 0.6 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP | C4967 |
| 30 | 5 | 10 |
|
| |
Injection containing dalteparin sodium 18,000 I.U. (anti-Xa) in 0.72 mL single dose pre-filled syringe | Injection |
| Fragmin | PF | MP NP | C4967 |
| 30 | 5 | 10 |
|
| |
Danazol | Capsule 100 mg | Oral |
| Azol 100 | AF | MP | C6242 C6259 C6285 C6293 |
| 100 | 5 | 100 |
|
|
Capsule 200 mg | Oral |
| Azol 200 | AF | MP | C6242 C6259 C6285 C6293 |
| 100 | 5 | 100 |
|
| |
Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
| Dantrium | PF | MP NP | C6359 |
| 100 | 2 | 100 |
|
|
Capsule containing dantrolene sodium hemiheptahydrate 50 mg | Oral |
| Dantrium | PF | MP NP | C6359 |
| 100 | 2 | 100 |
|
| |
Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | Oral |
| Forxiga | AP | MP | C4991 C5629 C7495 C7506 C7528 |
| 28 | 5 | 28 |
|
|
NP | C4991 C5629 C7495 C7506 |
| 28 | 5 | 28 |
|
| ||||||
Dapagliflozin with metformin | Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Xigduo XR 5/1000 | AP | MP | C5631 C5657 C5739 C5798 C7492 C7498 |
| 56 | 5 | 56 |
|
|
NP | C5631 C5657 C5739 C5798 C7492 |
| 56 | 5 | 56 |
|
| ||||||
Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | Oral |
| Xigduo XR 10/500 | AP | MP | C5631 C5657 C5739 C5798 C7492 C7498 |
| 28 | 5 | 28 |
|
| |
NP | C5631 C5657 C5739 C5798 C7492 |
| 28 | 5 | 28 |
|
| ||||||
Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Xigduo XR 10/1000 | AP | MP | C5631 C5657 C5739 C5798 C7492 C7498 |
| 28 | 5 | 28 |
|
| |
NP | C5631 C5657 C5739 C5798 C7492 |
| 28 | 5 | 28 |
|
| ||||||
Dapsone | Tablet 25 mg | Oral |
| Link Medical Products Pty Ltd | LM | MP NP |
|
| 100 | 1 | 100 |
|
|
Tablet 100 mg | Oral |
| Link Medical Products Pty Ltd | LM | MP NP |
|
| 100 | 1 | 100 |
|
| |
Darbepoetin alfa | Injection 10 micrograms in 0.4 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) |
Injection 20 micrograms in 0.5 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 20 micrograms in 0.5 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 30 micrograms in 0.3 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 40 micrograms in 0.4 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 40 micrograms in 0.4 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 50 micrograms in 0.5 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 60 micrograms in 0.3 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 60 micrograms in 0.3 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 80 micrograms in 0.4 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 80 micrograms in 0.4 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 100 micrograms in 0.5 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 100 micrograms in 0.5 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Injection 150 micrograms in 0.3 mL pre-filled injection pen | Injection |
| Aranesp SureClick | AN | MP | C6260 C6294 |
| 8 | 5 | 1 |
| D(100) | |
Injection 150 micrograms in 0.3 mL pre-filled syringe | Injection |
| Aranesp | AN | MP | C6260 C6294 |
| 8 | 5 | 4 |
| D(100) | |
Darunavir | Tablet 150 mg (as ethanolate) | Oral |
| Prezista | JC | MP | C5094 |
| 240 | 5 | 240 |
| D(100) |
Tablet 600 mg (as ethanolate) | Oral |
| Prezista | JC | MP | C5094 |
| 120 | 5 | 60 |
| D(100) | |
Tablet 800 mg (as ethanolate) | Oral |
| Prezista | JC | MP | C4313 |
| 60 | 5 | 30 |
| D(100) | |
Darunavir with cobicistat | Tablet containing darunavir 800 mg with cobicistat 150 mg | Oral |
| Prezcobix | JC | MP | C6377 C6413 C6428 |
| 60 | 5 | 30 |
| D(100) |
Dasatinib | Tablet 20 mg | Oral |
| Sprycel | BQ | MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6905 P6906 P6926 | 60 | 2 | 60 |
|
|
MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6702 P6731 P6947 P6959 P6968 | 60 | 5 | 60 |
|
| ||||||
Tablet 50 mg | Oral |
| Sprycel | BQ | MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6905 P6906 P6926 | 60 | 2 | 60 |
|
| |
MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6702 P6731 P6947 P6959 P6968 | 60 | 5 | 60 |
|
| ||||||
Tablet 70 mg | Oral |
| Sprycel | BQ | MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6905 P6906 P6926 | 60 | 2 | 60 |
|
| |
MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6702 P6731 P6947 P6959 P6968 | 60 | 5 | 60 |
|
| ||||||
Tablet 100 mg | Oral |
| Sprycel | BQ | MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6905 P6906 P6926 | 30 | 2 | 30 |
|
| |
MP | C6702 C6731 C6905 C6906 C6926 C6947 C6959 C6968 | P6702 P6731 P6947 P6959 P6968 | 30 | 5 | 30 |
|
| ||||||
Deferasirox | Tablet 90 mg | Oral |
| Jadenu | NM | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 180 | 2 | 30 |
| D(100) |
|
|
|
|
|
| MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 180 | 5 | 30 |
| D(100) |
| Tablet 180 mg | Oral |
| Jadenu | NM | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 180 | 2 | 30 |
| D (100) |
|
|
|
|
|
| MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 180 | 5 | 30 |
| D(100) |
| Tablet 360 mg | Oral |
| Jadenu | NM | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 180 | 2 | 30 |
| D(100) |
|
|
|
|
|
| MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 180 | 5 | 30 |
| D(100) |
| Tablet, dispersible, 125 mg | Oral |
| Exjade | NV | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 168 | 2 | 28 |
| D(100) |
MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 168 | 5 | 28 |
| D(100) | ||||||
Tablet, dispersible, 250 mg | Oral |
| Exjade | NV | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 168 | 2 | 28 |
| D(100) | |
MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 168 | 5 | 28 |
| D(100) | ||||||
Tablet, dispersible, 500 mg | Oral |
| Exjade | NV | MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7385 P8326 P8328 P8329 P8444 P8445 P8446 | 168 | 2 | 28 |
| D(100) | |
MP | C7374 C7375 C7385 C8326 C8328 C8329 C8444 C8445 C8446 | P7374 P7375 | 168 | 5 | 28 |
| D(100) | ||||||
Deferiprone | Oral solution 100 mg per mL, 250 mL | Oral |
| Ferriprox | TX | MP | C6380 C6403 C6442 C6448 |
| 5 | 5 | 1 |
| D(100) |
Tablet 500 mg | Oral |
| Ferriprox | TX | MP | C6380 C6403 C6442 C6448 |
| 600 | 5 | 100 |
| D(100) | |
Degarelix | Powder for injection 80 mg (as acetate), injection set | Injection |
| Firmagon 80mg | FP | MP | C6952 |
| 1 | 5 | 1 |
|
|
Powder for injection 120 mg (as acetate), 2, injection set | Injection |
| Firmagon 120mg | FP | MP | C6976 |
| 1 | 0 | 1 |
|
| |
Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection |
| Prolia | AN | MP NP | C6524 C6548 |
| 1 | 0 | 1 |
|
|
Injection 120 mg in 1.7 mL | Injection |
| Xgeva | AN | MP NP | C4150 C4158 C4504 |
| 1 | 5 | 1 |
|
| |
Desferrioxamine | Powder for injection containing desferrioxamine mesilate 500 mg | Injection |
| Hospira Pty Limited | PF | MP | C6394 C6408 |
| 400 | 5 | 10 |
| D(100) |
Powder for injection containing desferrioxamine mesilate 2 g | Injection |
| Hospira Pty Limited | PF | MP | C6394 C6408 |
| 60 | 5 | 1 |
| D(100) | |
Desmopressin | Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle | Nasal |
| Minirin | FP | MP | C5266 |
| 5 | 5 | 1 |
|
|
Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal |
| Minirin Nasal Spray | FP | MP | C5266 C5267 C5342 | P5267 P5342 | 1 | 5 | 1 |
|
| |
NP | C5267 C5342 |
| 1 | 5 | 1 |
|
| ||||||
MP | C5266 C5267 C5342 | P5266 | 2 | 5 | 1 |
|
| ||||||
Tablet containing desmopressin acetate 200 micrograms | Oral |
| Minirin | FP | MP | C5266 C5295 C5413 | P5295 P5413 | 30 | 5 | 30 |
|
| |
NP | C5295 C5413 |
| 30 | 5 | 30 |
|
| ||||||
MP | C5266 C5295 C5413 | P5266 | 90 | 5 | 30 |
|
| ||||||
Wafer 120 micrograms (as acetate) | Sublingual |
| Minirin Melt | FP | MP NP | C5226 C5412 |
| 30 | 5 | 30 |
|
| |
Wafer 240 micrograms (as acetate) | Sublingual |
| Minirin Melt | FP | MP NP | C5226 C5412 |
| 30 | 5 | 30 |
|
| |
Desvenlafaxine | Tablet (extended release) 50 mg (as succinate) | Oral | a | Pristiq | PF | MP NP | C5650 |
| 28 | 5 | 28 |
|
|
Tablet (modified release) 50 mg | Oral | a | Desfax | AF | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
a | DESVEN | RW | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Desvenlafaxine Actavis | EA | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Desvenlafaxine Sandoz | SZ | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
Tablet (modified release) 50 mg (as benzoate) | Oral | a | APO-Desvenlafaxine MR | TX | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
a | Desvenlafaxine GH XR | GQ | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
Tablet (extended release) 100 mg (as succinate) | Oral |
| Pristiq | PF | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
Tablet (modified release) 100 mg | Oral |
| Desfax | AF | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
| DESVEN | RW | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
| Desvenlafaxine Actavis | EA | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
| Desvenlafaxine Sandoz | SZ | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
Tablet (modified release) 100 mg (as benzoate) | Oral |
| APO-Desvenlafaxine MR | TX | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
| Desvenlafaxine GH XR | GQ | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
Dexamethasone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| Maxidex | NV | AO |
|
| 1 | 0 | 1 |
|
|
MP NP |
|
| 1 | 2 | 1 |
|
| ||||||
Intravitreal injection 700 micrograms | Implantation |
| Ozurdex | AG | MP | C7565 C7566 C7579 C8020 C8023 C8032 C8033 | P7566 | 1 | 0 | 1 |
|
| |
MP | C7565 C7566 C7579 C8020 C8023 C8032 C8033 | P7565 P7579 P8020 P8023 P8032 P8033 | 1 | 1 | 1 |
|
| ||||||
Tablet 500 micrograms | Oral |
| Dexmethsone | AS | MP NP |
|
| 30 | 4 | 30 |
|
| |
Tablet 4 mg | Oral |
| Dexmethsone | AS | MP NP |
|
| 30 | 4 | 30 |
|
| |
Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL | Injection | a | Dexamethasone Mylan | AF | MP NP |
|
| 5 | 0 | 5 |
|
| |
a | Hospira Pty Limited | PF | MP NP |
|
| 5 | 0 | 5 |
|
| |||
Injection containing dexamethasone sodium phosphate equivalent to 8 mg dexamethasone phosphate in 2 mL | Injection | a | Dexamethasone Mylan | AF | MP NP |
|
| 5 | 1 | 5 |
|
| |
a | Hospira Pty Limited | PF | MP NP |
|
| 5 | 1 | 5 |
|
| |||
Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | a | Otodex | AV | MP NP |
|
| 1 | 2 | 1 |
|
|
a | Sofradex | SW | MP NP |
|
| 1 | 2 | 1 |
|
| |||
Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg | Oral |
| Aspen Pharma Pty Ltd | QA | MP NP | C6226 C6227 |
| 100 | 5 | 100 |
|
|
Diazepam | Injection 10 mg in 2 mL | Injection |
| Hospira Pty Limited | PF | MP NP PDP |
|
| 5 | 0 | 5 |
|
|
Oral liquid 1 mg in 1 mL, 100 mL | Oral |
| Diazepam Elixir | ON | MP NP | C4244 |
| 1 | 0 | 1 |
|
| |
Tablet 2 mg | Oral | a | Antenex 2 | AF | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |
a | APO-Diazepam | TX | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
a | Valpam 2 | RW | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
a | Antenex 2 | AF | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
a | APO-Diazepam | TX | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
a | Valpam 2 | RW | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
Tablet 5 mg | Oral | a | Antenex 5 | AF | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |
a | APO-Diazepam | TX | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
a | Valium | RO | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
a | Valpam 5 | RW | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
a | Antenex 5 | AF | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
a | APO-Diazepam | TX | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
a | Valium | RO | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
a | Valpam 5 | RW | MP NP |
| P6176 | 50 | 3 | 50 |
|
| |||
Diclofenac | Suppository containing diclofenac sodium 100 mg | Rectal |
| Voltaren 100 | NV | PDP |
|
| 40 | 0 | 20 |
|
|
MP NP MW |
|
| 40 | 3 | 20 |
|
| ||||||
MP NP |
| P6149 | 40 | 3 | 20 |
|
| ||||||
Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | a | APO-Diclofenac | TX | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |
a | Clonac 25 | RW | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Diclofenac Amneal | ED | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Diclofenac AN | EA | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Diclofenac Sandoz | SZ | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Fenac 25 | AF | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Voltaren 25 | NV | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | APO-Diclofenac | TX | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Clonac 25 | RW | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Diclofenac Amneal | ED | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Diclofenac AN | EA | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Diclofenac Sandoz | SZ | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Fenac 25 | AF | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Voltaren 25 | NV | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | a | APO-Diclofenac | TX | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |
a | Clonac 50 | RW | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Diclofenac Amneal | ED | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Diclofenac AN | EA | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Diclofenac Sandoz | SZ | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Fenac | AF | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Pharmacor Diclofenac 50 | CR | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Voltaren 50 | NV | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | APO-Diclofenac | TX | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Clonac 50 | RW | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Diclofenac Amneal | ED | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Diclofenac AN | EA | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Diclofenac Sandoz | SZ | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Fenac | AF | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Pharmacor Diclofenac 50 | CR | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Voltaren 50 | NV | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | a | Dicloxacillin Mylan 250 | AL | PDP | C5268 |
| 24 | 0 | 24 |
|
|
MP NP MW | C5415 |
| 24 | 0 | 24 |
|
| ||||||
a | Distaph 250 | AF | PDP | C5268 |
| 24 | 0 | 24 |
|
| |||
MP NP MW | C5415 |
| 24 | 0 | 24 |
|
| ||||||
Capsule 500 mg (as sodium) | Oral | a | Dicloxacillin Mylan 500 | AL | MP | C5415 C6188 | P5415 | 24 | 0 | 24 |
|
| |
PDP | C5268 |
| 24 | 0 | 24 |
|
| ||||||
NP MW | C5415 |
| 24 | 0 | 24 |
|
| ||||||
a | Distaph 500 | AF | MP | C5415 C6188 | P5415 | 24 | 0 | 24 |
|
| |||
PDP | C5268 |
| 24 | 0 | 24 |
|
| ||||||
NP MW | C5415 |
| 24 | 0 | 24 |
|
| ||||||
a | Dicloxacillin Mylan 500 | AL | MP | C5415 C6188 | P6188 | 48 | 1 | 24 |
|
| |||
a | Distaph 500 | AF | MP | C5415 C6188 | P6188 | 48 | 1 | 24 |
|
| |||
Digoxin | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral |
| Lanoxin | QA | MP NP |
|
| 2 | 3 | 1 |
|
|
Tablet 62.5 micrograms | Oral | a | Lanoxin-PG | QA | MP NP |
|
| 200 | 1 | 200 |
|
| |
a | Sigmaxin-PG | FM | MP NP |
|
| 200 | 1 | 200 |
|
| |||
Tablet 250 micrograms | Oral | a | Lanoxin | QA | MP NP |
|
| 100 | 1 | 100 |
|
| |
a | Sigmaxin | FM | MP NP |
|
| 100 | 1 | 100 |
|
| |||
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | a | Cardizem CD | SW | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Vasocardol CD | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | a | Cardizem CD | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Vasocardol CD | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | a | Cardizem CD | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Vasocardol CD | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing diltiazem hydrochloride 60 mg | Oral | a | Cardizem | SW | MP NP |
|
| 90 | 5 | 90 |
|
| |
a | Diltiazem Actavis | ED | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Diltiazem AN | EA | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Diltiazem Sandoz | SZ | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Vasocardol | AV | MP NP |
|
| 90 | 5 | 90 |
|
| |||
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral |
| Tecfidera | BD | MP | C6920 C7732 |
| 28 | 0 | 14 |
|
|
Capsule (modified release) 240 mg | Oral |
| Tecfidera | BD | MP | C6913 |
| 56 | 5 | 56 |
|
| |
Diphenoxylate with atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral | a | Lofenoxal | IL | MP NP |
|
| 20 | 0 | 20 |
|
|
a | Lomotil | IM | MP NP |
|
| 20 | 0 | 20 |
|
| |||
Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | Injection |
| ADT Booster | CS | MP NP |
|
| 5 | 0 | 5 |
|
|
Dipyridamole | Capsule 200 mg (sustained release) | Oral |
| Persantin SR | BY | MP NP | C6385 C6411 C6473 |
| 60 | 5 | 60 |
|
|
Dipyridamole with aspirin | Capsule 200 mg (sustained release)-25 mg | Oral | a | Asasantin SR | BY | MP NP | C6424 |
| 60 | 5 | 60 |
|
|
a | Diasp SR | RW | MP NP | C6424 |
| 60 | 5 | 60 |
|
| |||
Disopyramide | Capsule 100 mg | Oral |
| Rythmodan | SW | MP NP |
|
| 100 | 5 | 100 |
|
|
Docetaxel | Solution concentrate for I.V. infusion 80 mg in 4 mL | Injection |
| Docetaxel Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution concentrate for I.V. infusion 80 mg in 8 mL | Injection |
| DBL Docetaxel Concentrated Injection | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Docetaxel Sandoz | SZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Solution concentrate for I.V. infusion 160 mg in 8 mL | Injection |
| Docetaxel Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Solution concentrate for I.V. infusion 160 mg in 16 mL | Injection |
| DBL Docetaxel Concentrated Injection | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Docosahexaenoic acid with carbohydrate | Sachets of oral powder 4 g containing 200 mg docosahexaenoic acid, 30 (docomega) | Oral |
| docomega | VF | MP NP | C6141 |
| 4 | 5 | 1 |
|
|
Dolutegravir | Tablet 50 mg (as sodium) | Oral |
| Tivicay | VI | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) |
Dolutegravir with abacavir and lamivudine | Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg | Oral |
| Triumeq | VI | MP | C4480 C4495 |
| 60 | 5 | 30 |
| D(100) |
Dolutegravir with rilpivirine | Tablet containing dolutegravir 50 mg (as sodium) with rilpivirine 25 mg (as hydrochloride) | Oral |
| Juluca | VI | MP | C8214 C8226 |
| 60 | 5 | 30 |
| D(100) |
Domperidone | Tablet 10 mg | Oral |
| Motilium | JC | MP NP |
|
| 25 | 0 | 25 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | a | APO-Donepezil | TX | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
|
a | Arazil | AF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aricept | PF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aridon 5 | RW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aridon APN 5 | RF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Donepezil | CH | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil AN | EA | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil GH | HQ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil Sandoz | SZ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil-DRLA | RZ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Donepezil | TW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
Tablet containing donepezil hydrochloride 10 mg | Oral | a | APO-Donepezil | TX | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |
a | Arazil | AF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aricept | PF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aridon 10 | RW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Aridon APN 10 | RF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Donepezil | CH | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil AN | EA | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil GH | HQ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil Sandoz | SZ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Donepezil-DRLA | RZ | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Pharmacor Donepezil 10 | CR | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Donepezil | TW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
Dornase alfa | Solution for inhalation 2.5 mg (2,500 units) in 2.5 mL | Inhalation |
| Pulmozyme | RO | MP | C5634 C5635 C5715 C5740 C5768 C5800 |
| 60 | 5 | 30 |
| D(100) |
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | a | APO-Dorzolamide | TX | AO MP |
|
| 1 | 5 | 1 |
|
|
a | Trusamide | QA | AO MP |
|
| 1 | 5 | 1 |
|
| |||
a | Trusopt | MF | AO MP |
|
| 1 | 5 | 1 |
|
| |||
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | a | APO-Dorzolamide/Timolol 20/5 | TX | AO | C5038 |
| 1 | 5 | 1 |
|
|
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Cosdor | QA | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Cosopt | MF | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | DORZOLAMIDE/TIMOLOL AN 20/5 | JU | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
Dosulepin | Capsule containing dosulepin hydrochloride 25 mg | Oral | a | Dosulepin Mylan | AL | MP NP |
|
| 50 | 2 | 50 |
|
|
a | Dothep 25 | AF | MP NP |
|
| 50 | 2 | 50 |
|
| |||
Tablet containing dosulepin hydrochloride 75 mg | Oral | a | Dosulepin Mylan | AL | MP NP |
|
| 30 | 2 | 30 |
|
| |
a | Dothep 75 | AF | MP NP |
|
| 30 | 2 | 30 |
|
| |||
Doxepin | Capsule 10 mg (as hydrochloride) | Oral |
| Deptran 10 | AF | MP NP |
|
| 50 | 2 | 50 |
|
|
| Sinequan | PF | MP NP |
|
| 50 | 2 | 50 |
|
| |||
Capsule 25 mg (as hydrochloride) | Oral |
| Deptran 25 | AF | MP NP |
|
| 50 | 2 | 50 |
|
| |
| Sinequan | PF | MP NP |
|
| 50 | 2 | 50 |
|
| |||
Tablet 50 mg (as hydrochloride) | Oral |
| Deptran 50 | AF | MP NP |
|
| 50 | 2 | 50 |
|
| |
Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical |
| Adriamycin | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical |
| Adriamycin | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Doxorubicin ACC | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | a | Caelyx | JC | MP | C4786 C4787 C4791 C6233 C6234 C6264 C6274 | P6233 P6234 P6264 P6274 | 4 | 5 | 1 |
| D(100) |
a | Liposomal Doxorubicin SUN | RA | MP | C4786 C4787 C4791 C6233 C6234 C6264 C6274 | P6233 P6234 P6264 P6274 | 4 | 5 | 1 |
| D(100) | |||
| Caelyx | JC | MP | C4786 C4787 C4791 C6233 C6234 C6264 C6274 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Liposomal Doxorubicin SUN | RA | MP | C4786 C4787 C4791 C6233 C6234 C6264 C6274 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 50 mg in 25 mL | Injection |
| Caelyx | JC | MP | C4786 C4787 C4791 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Liposomal Doxorubicin SUN | RA | MP | C4786 C4787 C4791 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Doxycycline | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral |
| Doryx | YN | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
|
| Mayne Pharma Doxycycline | YT | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |||
Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral |
| Doryx | YN | PDP |
|
| 7 | 0 | 7 |
|
| |
| Mayne Pharma Doxycycline | YT | PDP |
|
| 7 | 0 | 7 |
|
| |||
| Doryx | YN | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Mayne Pharma Doxycycline | YT | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doryx | YN | MP NP |
| P4485 | 21 | 0 | 21 |
|
| |||
| Mayne Pharma Doxycycline | YT | MP NP |
| P4485 | 21 | 0 | 21 |
|
| |||
| Doryx | YN | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Mayne Pharma Doxycycline | YT | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Doryx | YN | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
| Mayne Pharma Doxycycline | YT | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
Tablet 50 mg (as hyclate) | Oral |
| Doxycycline AN | EA | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |
| Doxylin 50 | AF | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |||
Tablet 50 mg (as monohydrate) | Oral |
| APO-Doxycycline | TX | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |
| Doxycycline Sandoz | HX | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |||
| Frakas | RW | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |||
| GenRx Doxycycline | GX | MP NP | C4475 C4529 C4539 |
| 25 | 5 | 25 |
|
| |||
Tablet 100 mg (as hyclate) | Oral |
| Doxsig | RW | PDP |
|
| 7 | 0 | 7 |
|
| |
| Doxycycline AN | EA | PDP |
|
| 7 | 0 | 7 |
|
| |||
| Doxylin 100 | AF | PDP |
|
| 7 | 0 | 7 |
|
| |||
| Doxsig | RW | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doxycycline AN | EA | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doxylin 100 | AF | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doxsig | RW | MP NP |
| P4485 | 21 | 0 | 7 |
|
| |||
| Doxycycline AN | EA | MP NP |
| P4485 | 21 | 0 | 7 |
|
| |||
MP NP |
| P4485 | 21 | 0 | 21 |
|
| ||||||
| Doxylin 100 | AF | MP NP |
| P4485 | 21 | 0 | 7 |
|
| |||
MP NP |
| P4485 | 21 | 0 | 21 |
|
| ||||||
| Doxsig | RW | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Doxycycline AN | EA | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Doxylin 100 | AF | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Doxsig | RW | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
| Doxycycline AN | EA | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
| Doxylin 100 | AF | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
Tablet 100 mg (as monohydrate) | Oral |
| APO-Doxycycline | TX | PDP |
|
| 7 | 0 | 7 |
|
| |
| Doxycycline Sandoz | HX | PDP |
|
| 7 | 0 | 7 |
|
| |||
| GenRx Doxycycline | GX | PDP |
|
| 7 | 0 | 7 |
|
| |||
| APO-Doxycycline | TX | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doxycycline Sandoz | HX | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| GenRx Doxycycline | GX | MP NP |
|
| 7 | 1 | 7 |
|
| |||
| Doxycycline Sandoz | HX | MP NP |
| P4485 | 21 | 0 | 7 |
|
| |||
| APO-Doxycycline | TX | MP NP |
| P4485 | 21 | 0 | 21 |
|
| |||
| GenRx Doxycycline | GX | MP NP |
| P4485 | 21 | 0 | 21 |
|
| |||
| APO-Doxycycline | TX | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| Doxycycline Sandoz | HX | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| GenRx Doxycycline | GX | MP NP |
| P4514 | 28 | 0 | 7 |
|
| |||
| APO-Doxycycline | TX | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
| Doxycycline Sandoz | HX | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
| GenRx Doxycycline | GX | MP |
| P6200 | 28 | 5 | 7 |
|
| |||
Dulaglutide | Injection 1.5 mg in 0.5 mL single dose pre-filled pen | Injection |
| Trulicity | LY | MP NP | C5478 C7645 |
| 4 | 5 | 4 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | a | Andepra | EL | MP NP | C5650 |
| 28 | 0 | 28 |
|
|
a | APO-Duloxetine | TX | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Chem mart Duloxetine | CH | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Cymbalta | LY | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Duloxetine AN | EA | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Duloxetine Sandoz | HX | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Duloxetine Sandoz 30 | SZ | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | DYTREX 30 | RW | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Terry White Chemists Duloxetine | TW | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
a | Tixol | AL | MP NP | C5650 |
| 28 | 0 | 28 |
|
| |||
Capsule 60 mg (as hydrochloride) | Oral | a | Andepra | EL | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |
a | APO-Duloxetine | TX | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Duloxetine | CH | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Cymbalta | LY | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Duloxetine AN | EA | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Duloxetine Sandoz | HX | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Duloxetine Sandoz 60 | SZ | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | DYTREX 60 | RW | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Duloxetine | TW | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
a | Tixol | AL | MP NP | C5650 |
| 28 | 5 | 28 |
|
| |||
Dutasteride | Capsule 500 micrograms | Oral | a | APO-Dutasteride | TX | MP NP | C6202 |
| 30 | 5 | 30 |
|
|
a | Avodart | GK | MP NP | C6202 |
| 30 | 5 | 30 |
|
| |||
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral |
| Duodart 500ug/400ug | GK | MP NP | C6189 |
| 30 | 5 | 30 |
|
|
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection |
| Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Efavirenz | Oral solution 30 mg per mL, 180 mL | Oral |
| Stocrin | MK | MP | C4454 C4512 |
| 7 | 5 | 1 |
| D(100) |
Tablet 200 mg | Oral |
| Stocrin | MK | MP | C4454 C4512 |
| 180 | 5 | 90 |
| D(100) | |
Tablet 600 mg | Oral |
| Stocrin | MK | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) | |
Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral | a | O.R.S. | AS | MP NP | C5889 |
| 1 | 0 | 1 |
|
|
a | restore O.R.S. | EA | MP | C5889 C6786 | P5889 | 1 | 0 | 1 |
|
| |||
NP | C5889 |
| 1 | 0 | 1 |
|
| ||||||
| restore O.R.S. | EA | MP | C5889 C6786 | P6786 | 30 | 0 | 1 |
|
| |||
Eletriptan | Tablet 40 mg (as hydrobromide) | Oral |
| Relpax | PF | MP NP | C5141 |
| 4 | 5 | 4 |
|
|
Tablet 80 mg (as hydrobromide) | Oral |
| Relpax | PF | MP NP | C5141 |
| 4 | 5 | 4 |
|
| |
Eltrombopag | Tablet 25 mg (as olamine) | Oral |
| Revolade | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 28 |
| D(100) |
Tablet 50 mg (as olamine) | Oral |
| Revolade | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 28 |
| D(100) | |
Empagliflozin | Tablet 10 mg | Oral |
| Jardiance | BY | MP | C4991 C5629 C7495 C7506 C7528 |
| 30 | 5 | 30 |
|
|
NP | C4991 C5629 C7495 C7506 |
| 30 | 5 | 30 |
|
| ||||||
Tablet 25 mg | Oral |
| Jardiance | BY | MP | C4991 C5629 C7495 C7506 C7528 |
| 30 | 5 | 30 |
|
| |
NP | C4991 C5629 C7495 C7506 |
| 30 | 5 | 30 |
|
| ||||||
Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | Oral |
| Glyxambi | BY | MP | C7524 C7556 |
| 30 | 5 | 30 |
|
|
NP | C7556 |
| 30 | 5 | 30 |
|
| ||||||
Tablet containing 25 mg empagliflozin with 5 mg linagliptin | Oral |
| Glyxambi | BY | MP | C7524 C7556 |
| 30 | 5 | 30 |
|
| |
NP | C7556 |
| 30 | 5 | 30 |
|
| ||||||
Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| Jardiamet 5 mg/1000 mg | BY | MP | C5657 C5798 C5953 C5966 C7492 C7498 |
| 60 | 5 | 60 |
|
|
NP | C5657 C5798 C5966 C7492 |
| 60 | 5 | 60 |
|
| ||||||
Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
| Jardiamet 5 mg/500 mg | BY | MP | C5657 C5798 C5953 C5966 C7492 C7498 |
| 60 | 5 | 60 |
|
| |
NP | C5657 C5798 C5966 C7492 |
| 60 | 5 | 60 |
|
| ||||||
Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| Jardiamet 12.5 mg/1000 mg | BY | MP | C5657 C5798 C5953 C5966 C7492 C7498 |
| 60 | 5 | 60 |
|
| |
NP | C5657 C5798 C5966 C7492 |
| 60 | 5 | 60 |
|
| ||||||
Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
| Jardiamet 12.5 mg/500 mg | BY | MP | C5657 C5798 C5953 C5966 C7492 C7498 |
| 60 | 5 | 60 |
|
| |
NP | C5657 C5798 C5966 C7492 |
| 60 | 5 | 60 |
|
| ||||||
Emtricitabine with rilpivirine with tenofovir alafenamide | Tablet containing emtricitabine 200 mg with rilpivirine 25 mg with tenofovir alafenamide 25 mg | Oral |
| Odefsey | GI | MP | C4470 C4522 |
| 60 | 5 | 30 |
| D(100) |
Emtricitabine with tenofovir alafenamide | Tablet containing emtricitabine 200 mg with tenofovir alafenamide 10 mg | Oral |
| Descovy | GI | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) |
Tablet containing emtricitabine 200 mg with tenofovir alafenamide 25 mg | Oral |
| Descovy | GI | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) | |
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | a | Acetec | AL | MP NP |
|
| 30 | 5 | 30 |
|
|
a | APO-Enalapril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Actavis | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Malean | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing enalapril maleate 10 mg | Oral | a | Acetec | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | APO-Enalapril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Actavis | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Malean | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Renitec | MK | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing enalapril maleate 20 mg | Oral | a | Acetec | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | APO-Enalapril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Actavis | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Malean | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Renitec 20 | MK | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | a | Enalapril/HCT Sandoz | SZ | MP NP | C4389 |
| 30 | 5 | 30 |
|
|
a | Renitec Plus 20/6 | MK | MP NP | C4389 |
| 30 | 5 | 30 |
|
| |||
Enfuvirtide | Pack containing 60 vials powder for injection 90 mg with 60 vials water for injections 1.1 mL (with syringes and swabs) | Injection |
| Fuzeon | RO | MP | C5014 |
| 2 | 5 | 1 |
| D(100) |
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | a | Clexane | SW | MP NP |
|
| 20 | 0 | 10 |
|
|
a | Enoxaparin Winthrop | WA | MP NP |
|
| 20 | 0 | 10 |
|
| |||
a | Clexane | SW | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
a | Enoxaparin Winthrop | WA | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | a | Clexane | SW | MP NP |
|
| 20 | 0 | 10 |
|
| |
a | Enoxaparin Winthrop | WA | MP NP |
|
| 20 | 0 | 10 |
|
| |||
a | Clexane | SW | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
a | Enoxaparin Winthrop | WA | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | a | Clexane | SW | MP NP |
|
| 10 | 1 | 10 |
|
| |
a | Enoxaparin Winthrop | WA | MP NP |
|
| 10 | 1 | 10 |
|
| |||
a | Clexane | SW | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
a | Enoxaparin Winthrop | WA | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | a | Clexane | SW | MP NP |
|
| 10 | 1 | 10 |
|
| |
a | Enoxaparin Winthrop | WA | MP NP |
|
| 10 | 1 | 10 |
|
| |||
a | Clexane | SW | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
a | Enoxaparin Winthrop | WA | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | a | Clexane | SW | MP NP |
|
| 10 | 1 | 10 |
|
| |
a | Enoxaparin Winthrop | WA | MP NP |
|
| 10 | 1 | 10 |
|
| |||
a | Clexane | SW | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
a | Enoxaparin Winthrop | WA | MP NP |
| P4910 | 20 | 3 | 10 |
|
| |||
Entacapone | Tablet 200 mg | Oral |
| Comtan | NV | MP NP | C5133 |
| 200 | 4 | 100 |
|
|
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | a | Baraclude | BQ | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) |
a | ENTAC | LR | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Amneal | EA | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir APOTEX | TX | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir GH | GQ | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Mylan | AF | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | ENTECAVIR RBX | RA | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Sandoz | SZ | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
a | ENTECLUDE | RW | MP | C4993 C5036 |
| 60 | 5 | 30 |
| D(100) | |||
Tablet 1 mg (as monohydrate) | Oral | a | Baraclude | BQ | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |
a | ENTAC | LR | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Amneal | EA | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir APOTEX | TX | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir GH | GQ | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Mylan | AF | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | ENTECAVIR RBX | RA | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | Entecavir Sandoz | SZ | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
a | ENTECLUDE | RW | MP | C5037 C5044 |
| 60 | 5 | 30 |
| D(100) | |||
Enzalutamide | Capsule 40 mg | Oral |
| Xtandi | LL | MP | C4670 |
| 112 | 2 | 112 |
|
|
Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/intravesical |
| Epirube | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
| Epirubicin ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pharmorubicin | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/intravesical |
| Epirubicin ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical |
| Epirube | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Epirubicin Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Epirubicin ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pharmorubicin | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Eplerenone | Tablet 25 mg | Oral | a | APO-Eplerenone | TX | MP NP | C4937 |
| 30 | 5 | 30 |
|
|
a | Eplerenone AN | EA | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | ESPLER | RW | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | Inpler | AF | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | Inspra | PF | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
Tablet 50 mg | Oral | a | APO-Eplerenone | TX | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |
a | Eplerenone AN | EA | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | ESPLER | RW | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | Inpler | AF | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
a | Inspra | PF | MP NP | C4937 |
| 30 | 5 | 30 |
|
| |||
Epoetin alfa | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection |
| Eprex 1000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) |
Injection 2,000 units in 0.5 mL pre-filled syringe | Injection |
| Eprex 2000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 3,000 units in 0.3 mL pre-filled syringe | Injection |
| Eprex 3000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 4,000 units in 0.4 mL pre-filled syringe | Injection |
| Eprex 4000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 5,000 units in 0.5 mL pre-filled syringe | Injection |
| Eprex 5000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 6,000 units in 0.6 mL pre-filled syringe | Injection |
| Eprex 6000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 8,000 units in 0.8 mL pre-filled syringe | Injection |
| Eprex 8000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 10,000 units in 1 mL pre-filled syringe | Injection |
| Eprex 10000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 20,000 units in 0.5 mL pre-filled syringe | Injection |
| Eprex 20,000 | JC | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 40,000 units in 1 mL pre-filled syringe | Injection |
| Eprex 40,000 | JC | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Epoetin beta | Injection 2,000 units in 0.3 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) |
Injection 3,000 units in 0.3 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 4,000 units in 0.3 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 5,000 units in 0.3 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 6,000 units in 0.3 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 10,000 units in 0.6 mL pre-filled syringe | Injection |
| NeoRecormon | RO | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Epoetin lambda | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) |
Injection 2,000 units in 1 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 3,000 units in 0.3 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 4,000 units in 0.4 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 5,000 units in 0.5 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 6,000 units in 0.6 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 8,000 units in 0.8 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Injection 10,000 units in 1 mL pre-filled syringe | Injection |
| Novicrit | SZ | MP | C6260 C6294 |
| 12 | 5 | 6 |
| D(100) | |
Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) | Injection |
| Veletri | AT | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Powder for I.V. infusion 500 micrograms (as sodium) with 2 vials diluent 50 mL | Injection |
| Flolan | GK | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Powder for I.V. infusion 1.5 mg (as sodium) | Injection |
| Veletri | AT | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Powder for I.V. infusion 1.5 mg (as sodium) with 2 vials diluent 50 mL | Injection |
| Flolan | GK | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Eprosartan | Tablet 400 mg (as mesilate) | Oral |
| Teveten | GO | MP NP |
|
| 56 | 5 | 28 |
|
|
MP NP |
| P6328 P6329 P6332 P6351 | 56 | 5 | 28 |
|
| ||||||
Tablet 600 mg (as mesilate) | Oral |
| Teveten | GO | MP NP |
|
| 28 | 5 | 28 |
|
| |
MP NP |
| P6328 P6329 P6332 P6351 | 28 | 5 | 28 |
|
| ||||||
Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | Oral |
| Teveten Plus 600/12.5 | GO | MP NP | C4374 |
| 28 | 5 | 28 |
|
|
Eptifibatide | Solution for I.V. injection 20 mg (as acetate) in 10 mL | Injection |
| Integrilin | MK | MP | C6435 |
| 2 | 0 | 1 |
|
|
Solution for I.V. infusion 75 mg (as acetate) in 100 mL | Injection |
| Integrilin | MK | MP | C6435 |
| 3 | 0 | 1 |
|
| |
Eribulin | Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL | Injection |
| Halaven | EI | MP | C4649 C7258 C7280 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Erlotinib | Tablet 25 mg (as hydrochloride) | Oral |
| Tarceva | RO | MP | C4473 C4600 C7446 |
| 30 | 3 | 30 |
|
|
Tablet 100 mg (as hydrochloride) | Oral |
| Tarceva | RO | MP | C4473 C4600 C7446 |
| 30 | 3 | 30 |
|
| |
Tablet 150 mg (as hydrochloride) | Oral |
| Tarceva | RO | MP | C4473 C4600 C7446 |
| 30 | 3 | 30 |
|
| |
Ertugliflozin | Tablet 5 mg | Oral |
| Steglatro 5 | MK | MP | C7495 C7506 C7528 |
| 28 | 5 | 28 |
|
|
|
|
|
|
|
| NP | C7495 C7506 |
| 28 | 5 | 28 |
|
|
| Tablet 15 mg | Oral |
| Steglatro 15 | MK | MP | C7495 C7506 C7528 |
| 28 | 5 | 28 |
|
|
|
|
|
|
|
| NP | C7495 C7506 |
| 28 | 5 | 28 |
|
|
Ertugliflozin with metformin | Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
| Segluromet 2.5/500 | MK | MP | C5631 C7492 C7498 C8249 |
| 56 | 5 | 56 |
|
|
|
|
|
|
|
| NP | C5631 C7492 C8249 |
| 56 | 5 | 56 |
|
|
| Tablet containing 2.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| Segluromet 2.5/1000 | MK | MP | C5631 C7492 C7498 C8249 |
| 56 | 5 | 56 |
|
|
|
|
|
|
|
| NP | C5631 C7492 C8249 |
| 56 | 5 | 56 |
|
|
| Tablet containing 7.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
| Segluromet 7.5/500 | MK | MP | C5631 C7492 C7498 C8249 |
| 56 | 5 | 56 |
|
|
|
|
|
|
|
| NP | C5631 C7492 C8249 |
| 56 | 5 | 56 |
|
|
| Tablet containing 7.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| Segluromet 7.5/1000 | MK | MP | C5631 C7492 C7498 C8249 |
| 56 | 5 | 56 |
|
|
|
|
|
|
|
| NP | C5631 C7492 C8249 |
| 56 | 5 | 56 |
|
|
Ertugliflozin with sitagliptin | Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin | Oral |
| Steglujan 5/100 | MK | MP | C7524 C7556 |
| 28 | 5 | 28 |
|
|
|
|
|
|
|
| NP | C7556 |
| 28 | 5 | 28 |
|
|
| Tablet containing 15 mg ertugliflozin with 100 mg sitagliptin | Oral |
| Steglujan 15/100 | MK | MP | C7524 C7556 |
| 28 | 5 | 28 |
|
|
|
|
|
|
|
| NP | C7556 |
| 28 | 5 | 28 |
|
|
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | a | Eryc | YN | PDP |
|
| 25 | 0 | 25 |
|
|
a | Mayne Pharma Erythromycin | YT | PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Eryc | YN | MP NP |
|
| 25 | 1 | 25 |
|
| |||
a | Mayne Pharma Erythromycin | YT | MP NP |
|
| 25 | 1 | 25 |
|
| |||
a | Eryc | YN | MP |
| P6160 | 50 | 5 | 25 |
|
| |||
a | Mayne Pharma Erythromycin | YT | MP |
| P6160 | 50 | 5 | 25 |
|
| |||
Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | a | E-Mycin 200 | AF | PDP |
|
| 1 | 0 | 1 |
|
| |
a | E.E.S. 200 | GH | PDP |
|
| 1 | 0 | 1 |
|
| |||
a | E-Mycin 200 | AF | MP NP |
|
| 1 | 1 | 1 |
|
| |||
a | E.E.S. 200 | GH | MP NP |
|
| 1 | 1 | 1 |
|
| |||
Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | a | E-Mycin 400 | AF | PDP |
|
| 1 | 0 | 1 |
|
| |
a | E.E.S. Granules | GH | PDP |
|
| 1 | 0 | 1 |
|
| |||
a | E-Mycin 400 | AF | MP NP |
|
| 1 | 1 | 1 |
|
| |||
a | E.E.S. Granules | GH | MP NP |
|
| 1 | 1 | 1 |
|
| |||
Tablet 400 mg (as ethyl succinate) | Oral |
| E-Mycin | AF | PDP |
|
| 25 | 0 | 25 |
|
| |
MP NP |
|
| 25 | 1 | 25 |
|
| ||||||
MP |
| P6160 | 50 | 5 | 25 |
|
| ||||||
Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral |
| Lexapro | LU | MP NP | C4680 C4681 C4707 C4721 C4747 |
| 1 | 5 | 1 |
|
|
Tablet 10 mg (as oxalate) | Oral | a | APO-Escitalopram | TX | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |
a | Blooms the Chemist Escitalopram | IB | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Escitalopram | CH | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Cilopam-S | ER | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram AN | EA | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram GH | HQ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram Sandoz | HX | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram-DRLA | RZ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Esipram | CF | MP NP | C4690 C4703 C4755 C4756 C4757 |
| 28 | 5 | 28 |
|
| |||
a | Esitalo | SZ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Lexam 10 | RW | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Lexapro | LU | MP NP | C4690 C4703 C4755 C4756 C4757 |
| 28 | 5 | 28 |
|
| |||
a | LoxaLate | AF | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Pharmacor Escitalopram 10 | CR | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Escitalopram | TW | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
Tablet 20 mg (as oxalate) | Oral | a | APO-Escitalopram | TX | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |
a | Blooms the Chemist Escitalopram | IB | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Escitalopram | CH | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Cilopam-S | ER | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram AN | EA | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram GH | HQ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram Sandoz | HX | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Escitalopram-DRLA | RZ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Esipram | CF | MP NP | C4690 C4703 C4755 C4756 C4757 |
| 28 | 5 | 28 |
|
| |||
a | Esitalo | SZ | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Lexam 20 | RW | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Lexapro | LU | MP NP | C4690 C4703 C4755 C4756 C4757 |
| 28 | 5 | 28 |
|
| |||
a | LoxaLate | AF | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Pharmacor Escitalopram 20 | CR | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Escitalopram | TW | MP NP | C4755 |
| 28 | 5 | 28 |
|
| |||
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral |
| Esomeprazole ACTAVIS | EA | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
|
| Noxicid Caps | AL | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole ACTAVIS | EA | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Noxicid Caps | AL | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
Capsule (enteric) 40 mg (as magnesium) | Oral |
| Esomeprazole ACTAVIS | EA | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |
| Noxicid Caps | AL | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole ACTAVIS | EA | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Noxicid Caps | AL | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral |
| Esomeprazole Apotex | TX | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |
| Esomeprazole GH | GQ | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole GxP | AF | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole RBX | RA | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole Sandoz | SZ | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole SZ | HX | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Nexazole | RW | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Nexium | AP | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Nexole | RF | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Pharmacor Esomeprazole | CR | MP NP | C4988 C5029 C5030 C5039 | P4988 | 30 | 1 | 30 |
|
| |||
| Esomeprazole Apotex | TX | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Esomeprazole GH | GQ | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Esomeprazole GxP | AF | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Esomeprazole RBX | RA | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Esomeprazole Sandoz | SZ | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Esomeprazole SZ | HX | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Nexazole | RW | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Nexium | AP | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Nexole | RF | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
| Pharmacor Esomeprazole | CR | MP NP | C4988 C5029 C5030 C5039 | P5029 P5030 P5039 | 30 | 5 | 30 |
|
| |||
Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral |
| Esomeprazole Apotex | TX | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |
| Esomeprazole GH | GQ | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole GxP | AF | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole RBX | RA | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole Sandoz | SZ | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole SZ | HX | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Nexazole | RW | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Nexium | AP | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Nexole | RF | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Pharmacor Esomeprazole | CR | MP NP | C5011 C5021 C5028 | P5028 | 30 | 1 | 30 |
|
| |||
| Esomeprazole Apotex | TX | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Esomeprazole GH | GQ | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Esomeprazole GxP | AF | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Esomeprazole RBX | RA | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Esomeprazole Sandoz | SZ | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Esomeprazole SZ | HX | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Nexazole | RW | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Nexium | AP | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Nexole | RF | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
| Pharmacor Esomeprazole | CR | MP NP | C5011 C5021 C5028 | P5011 P5021 | 30 | 5 | 30 |
|
| |||
Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
| ESOMEPRAZOLE SANDOZ Hp7 | SZ | MP NP | C6118 |
| 1 | 0 | 1 |
|
|
Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
| Nexium Hp7 | AP | MP NP | C6118 |
| 1 | 0 | 1 |
|
| |
Essential amino acids formula | Oral powder 200 g (Essential Amino Acid Mix) | Oral |
| Essential Amino Acid Mix | SB | MP NP | C4925 C4958 |
| 6 | 5 | 1 |
|
|
Essential amino acids formula with minerals and vitamin c | Oral powder 400 g (Dialamine) | Oral |
| Dialamine | SB | MP NP | C4925 C4958 |
| 5 | 5 | 1 |
|
|
Essential amino acids formula with vitamins and minerals | Sachets containing oral powder 12.5 g, 50 (EAA Supplement) | Oral |
| EAA Supplement | VF | MP NP | C4925 C4958 |
| 4 | 5 | 1 |
|
|
Estradiol | Transdermal patches 390 micrograms, 8 | Transdermal |
| Estradot 25 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
|
Transdermal patches 585 micrograms, 8 | Transdermal |
| Estradot 37.5 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal |
| Estraderm MX 25 | JU | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 780 micrograms, 8 | Transdermal |
| Estradot 50 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 1.17 mg, 8 | Transdermal |
| Estradot 75 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal |
| Estraderm MX 50 | JU | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 1.56 mg, 8 | Transdermal |
| Estradot 100 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 2 mg, 4 | Transdermal |
| Climara 25 | BN | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal |
| Estraderm MX 100 | JU | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 3.8 mg, 4 | Transdermal |
| Climara 50 | BN | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 5.7 mg, 4 | Transdermal |
| Climara 75 | BN | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal patches 7.6 mg, 4 | Transdermal |
| Climara 100 | BN | MP NP |
|
| 1 | 5 | 1 |
|
| |
Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal |
| Sandrena | AS | MP NP |
|
| 1 | 5 | 1 |
|
| |
Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal |
| Vagifem Low | NO | MP NP |
|
| 18 | 2 | 18 |
|
| |
Tablet containing estradiol valerate 1 mg | Oral |
| Progynova | BN | MP NP |
|
| 56 | 2 | 56 |
|
| |
Tablet 2 mg | Oral |
| Zumenon | GO | MP NP |
|
| 56 | 2 | 56 |
|
| |
Tablet containing estradiol valerate 2 mg | Oral |
| Progynova | BN | MP NP |
|
| 56 | 2 | 56 |
|
| |
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | Oral |
| Femoston 1/10 | GO | MP NP |
|
| 1 | 5 | 1 |
|
|
Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | Oral |
| Femoston 2/10 | GO | MP NP |
|
| 1 | 5 | 1 |
|
| |
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal |
| Estalis sequi 50/250 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
|
Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal |
| Estalis sequi 50/140 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Estradiol with dydrogesterone | Tablet 1 mg-5 mg | Oral |
| Femoston-Conti | GO | MP NP |
|
| 28 | 5 | 28 |
|
|
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal |
| Estalis continuous 50/250 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
|
Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal |
| Estalis continuous 50/140 | SZ | MP NP |
|
| 1 | 5 | 1 |
|
| |
Estriol | Vaginal cream 1 mg per g, 15 g | Application |
| Ovestin | AS | MP NP |
|
| 1 | 1 | 1 |
|
|
Pessaries 500 micrograms, 15 | Vaginal |
| Ovestin Ovula | AS | MP NP |
|
| 1 | 2 | 1 |
|
| |
Etacrynic acid | Tablet 25 mg | Oral |
| Edecrin | FK | MP NP | C4936 |
| 200 | 1 | 100 |
|
|
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection |
| Enbrel | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| C(100) |
|
|
|
|
|
| MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4458 P4483 P4503 P6808 P6811 P6814 P6818 P6819 P6822 P6823 P6830 P6836 P6843 P7177 P7220 P7224 P7288 P7308 P7336 P8039 P8040 P8093 P8631 P8638 P8661 P8760 | 2 | 3 | 1 |
|
|
|
|
|
|
|
| MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4457 P4482 P7181 P7219 P7251 P7287 P7289 P7300 P7307 P7320 P8054 P8079 P8095 P8103 P8662 P8692 P8718 | 2 | 5 | 1 |
|
|
| Injection 50 mg in 1 mL single use auto-injector, 4 | Injection |
| Enbrel | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| C(100) |
|
|
|
| Brenzys | MK | MP | C6808 C6836 C7177 C7181 C7217 C7219 C7220 C7224 C7276 C7288 C7289 C7296 C7300 C7308 C7317 C7320 C7336 C8039 C8040 C8079 C8092 C8093 C8095 C8631 C8638 C8661 C8662 C8718 C8760 | P6808 P6836 P7177 P7220 P7224 P7288 P7308 P7336 P8039 P8040 P8093 P8631 P8638 P8661 P8760 | 1 | 3 | 1 |
|
|
|
|
|
| Enbrel | PF | MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4458 P4483 P4503 P6808 P6811 P6814 P6818 P6819 P6822 P6823 P6830 P6836 P6843 P7177 P7220 P7224 P7288 P7308 P7336 P8039 P8040 P8093 P8631 P8638 P8661 P8760 | 1 | 3 | 1 |
|
|
|
|
|
| Brenzys | MK | MP | C6808 C6836 C7177 C7181 C7217 C7219 C7220 C7224 C7276 C7288 C7289 C7296 C7300 C7308 C7317 C7320 C7336 C8039 C8040 C8079 C8092 C8093 C8095 C8631 C8638 C8661 C8662 C8718 C8760 | P7181 P7217 P7219 P7276 P7289 P7296 P7300 P7317 P7320 P8079 P8092 P8095 P8662 P8718 | 1 | 5 | 1 |
|
|
|
|
|
| Enbrel | PF | MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4457 P4482 P7181 P7219 P7251 P7287 P7289 P7300 P7307 P7320 P8054 P8079 P8095 P8103 P8662 P8692 P8718 | 1 | 5 | 1 |
|
|
| Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection |
| Enbrel | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| C(100) |
|
|
|
| Brenzys | MK | MP | C6808 C6836 C7177 C7181 C7217 C7219 C7220 C7224 C7276 C7288 C7289 C7296 C7300 C7308 C7317 C7320 C7336 C8039 C8040 C8079 C8092 C8093 C8095 C8631 C8638 C8661 C8662 C8718 C8760 | P6808 P6836 P7177 P7220 P7224 P7288 P7308 P7336 P8039 P8040 P8093 P8631 P8638 P8661 P8760 | 1 | 3 | 1 |
|
|
|
|
|
| Enbrel | PF | MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4458 P4483 P4503 P6808 P6811 P6814 P6818 P6819 P6822 P6823 P6830 P6836 P6843 P7177 P7220 P7224 P7288 P7308 P7336 P8039 P8040 P8093 P8631 P8638 P8661 P8760 | 1 | 3 | 1 |
|
|
|
|
|
| Brenzys | MK | MP | C6808 C6836 C7177 C7181 C7217 C7219 C7220 C7224 C7276 C7288 C7289 C7296 C7300 C7308 C7317 C7320 C7336 C8039 C8040 C8079 C8092 C8093 C8095 C8631 C8638 C8661 C8662 C8718 C8760 | P7181 P7217 P7219 P7276 P7289 P7296 P7300 P7317 P7320 P8079 P8092 P8095 P8662 P8718 | 1 | 5 | 1 |
|
|
|
|
|
| Enbrel | PF | MP | C4457 C4458 C4482 C4483 C4503 C6808 C6811 C6814 C6818 C6819 C6822 C6823 C6830 C6836 C6843 C7177 C7181 C7219 C7220 C7224 C7251 C7287 C7288 C7289 C7300 C7307 C7308 C7320 C7336 C8039 C8040 C8054 C8079 C8093 C8095 C8103 C8631 C8638 C8661 C8662 C8692 C8718 C8760 | P4457 P4482 P7181 P7219 P7251 P7287 P7289 P7300 P7307 P7320 P8054 P8079 P8095 P8103 P8662 P8692 P8718 | 1 | 5 | 1 |
|
|
Ethosuximide | Capsule 250 mg | Oral |
| Zarontin | IX | MP NP |
|
| 200 | 2 | 200 |
|
|
Oral solution 250 mg per 5 mL, 200 mL | Oral |
| Zarontin | IX | MP NP |
|
| 1 | 5 | 1 |
|
| |
Etonogestrel | Subcutaneous implant 68 mg | Implantation |
| Implanon NXT | MK | MP NP MW |
|
| 1 | 0 | 1 |
|
|
Etoposide | Capsule 50 mg | Oral |
| Vepesid | BQ | MP |
|
| 20 | 0 | 20 |
|
|
Capsule 100 mg | Oral |
| Vepesid | BQ | MP |
|
| 10 | 0 | 10 |
|
| |
Powder for I.V. infusion 1 g (as phosphate) | Injection |
| Etopophos | BQ | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
Solution for I.V. infusion 100 mg in 5 mL | Injection |
| Pfizer Australia Pty Ltd | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
| Etoposide Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 5 |
| PB(100) | |||
Etravirine | Tablet 200 mg | Oral |
| Intelence | JC | MP | C5014 |
| 120 | 5 | 60 |
| D(100) |
Everolimus | Tablet 0.25 mg | Oral |
| Certican | NV | MP |
|
| 60 | 3 | 60 |
|
|
|
|
|
|
|
| MP |
| P5554 P5555 P5794 P5795 | 120 | 5 | 60 |
| C(100) |
| Tablet 0.5 mg | Oral |
| Certican | NV | MP |
|
| 60 | 3 | 60 |
|
|
|
|
|
|
|
| MP |
| P5554 P5555 P5794 P5795 | 120 | 5 | 60 |
| C(100) |
| Tablet 0.75 mg | Oral |
| Certican | NV | MP |
|
| 120 | 3 | 60 |
|
|
|
|
|
|
|
| MP |
| P5554 P5555 P5794 P5795 | 240 | 5 | 60 |
| C(100) |
| Tablet 1 mg | Oral |
| Certican | NV | MP |
|
| 120 | 3 | 60 |
|
|
|
|
|
|
|
| MP |
| P5554 P5555 P5794 P5795 | 240 | 5 | 60 |
| C(100) |
| Tablet, dispersible, 2 mg | Oral |
| Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 | 30 |
|
|
| Tablet 2.5 mg | Oral |
| Afinitor | NV | MP | C4351 C7431 |
| 30 | 5 | 30 |
|
|
| Tablet, dispersible, 3 mg | Oral |
| Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 | 30 |
|
|
| Tablet, dispersible, 5mg | Oral |
| Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 | 30 |
|
|
| Tablet 5 mg | Oral |
| Afinitor | NV | MP | C4351 C4812 C4837 C4861 C7431 C7432 C8622 | P4861 P8622 | 30 | 2 | 30 |
|
|
|
|
|
| Everolimus Sandoz | SZ | MP | C4837 C4861 | P4861 | 30 | 2 | 30 |
|
|
|
|
|
| Afinitor | NV | MP | C4351 C4812 C4837 C4861 C7431 C7432 C8622 | P4351 P4812 P4837 P7431 P7432 | 30 | 5 | 30 |
|
|
|
|
|
| Everolimus Sandoz | SZ | MP | C4837 C4861 | P4837 | 30 | 5 | 30 |
|
|
| Tablet 10 mg | Oral |
| Afinitor | NV | MP | C4351 C4812 C4837 C4861 C7431 C7432 C8622 | P4861 P8622 | 30 | 2 | 30 |
|
|
|
|
|
| Everolimus Sandoz | SZ | MP | C4837 C4861 | P4861 | 30 | 2 | 30 |
|
|
|
|
|
| Afinitor | NV | MP | C4351 C4812 C4837 C4861 C7431 C7432 C8622 | P4351 P4812 P4837 P7431 P7432 | 30 | 5 | 30 |
|
|
|
|
|
| Everolimus Sandoz | SZ | MP | C4837 C4861 | P4837 | 30 | 5 | 30 |
|
|
Evolocumab | Injection 140 mg in 1 mL single use pre-filled pen | Injection |
| Repatha | AN | MP | C6597 C8064 C8078 C8094 C8108 | P8064 P8078 P8108 | 2 | 5 | 1 |
|
|
|
|
|
|
|
| MP | C6597 C8064 C8078 C8094 C8108 | P6597 P8094 | 3 | 5 | 1 |
|
|
| Injection 420 mg in 3.5 mL single use pre-filled cartridge | Injection |
| Repatha | AN | MP | C6597 C8064 C8078 C8094 C8108 |
| 1 | 5 | 1 |
|
|
Exemestane | Tablet 25 mg | Oral | a | APO-Exemestane | TX | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
|
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Aromasin | PF | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Estamane | JU | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Exaccord | RA | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Exemestane AN | EA | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Exemestane GH | GQ | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
a | Exemestane Sandoz | SZ | MP | C4796 C5522 |
| 30 | 5 | 30 |
|
| |||
NP | C5522 |
| 30 | 5 | 30 |
|
| ||||||
Exenatide | Injection solution 5 micrograms per dose in pre-filled pen, 60 doses | Injection |
| Byetta 5 microgram | AP | MP NP | C5469 C5478 C5500 |
| 1 | 5 | 1 |
|
|
Injection solution 10 micrograms per dose in pre-filled pen, 60 doses | Injection |
| Byetta 10 microgram | AP | MP NP | C5469 C5478 C5500 |
| 1 | 5 | 1 |
|
| |
Injection (modified release) 2 mg single dose pre-filled pen | Injection |
| Bydureon | AP | MP NP | C6505 C6519 |
| 4 | 5 | 4 |
|
| |
Ezetimibe | Tablet 10 mg | Oral | a | APO-Ezetimibe | TX | MP NP | C7966 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Blooms The Chemist Ezetimibe | IB | MP NP | C7966 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | EZEMICHOL | RW | MP NP | C7966 C7990 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Ezetimibe GH | GQ | MP NP | C7966 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Ezetimibe Sandoz | SZ | MP NP | C7966 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Ezetrol | MK | MP NP | C7966 C7990 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Pharmacor Ezetimibe 10 | CR | MP NP | C7966 C7990 C7996 |
| 30 | 5 | 30 |
|
|
|
|
| a | Zient 10mg | AF | MP NP | C7966 C7990 C7996 |
| 30 | 5 | 30 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | a | Ezalo Composite Pack 10mg+5mg | AF | MP NP | C7958 |
| 1 | 5 | 1 |
|
|
a | Rosuzet Composite Pack | MK | MP NP | C7958 |
| 1 | 5 | 1 |
|
| |||
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | a | Ezalo Composite Pack 10mg+10mg | AF | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |
a | Rosuzet Composite Pack | MK | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |||
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | a | Ezalo Composite Pack 10mg+20mg | AF | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |
a | Rosuzet Composite Pack | MK | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |||
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | a | Ezalo Composite Pack 10mg+40mg | AF | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |
a | Rosuzet Composite Pack | MK | MP NP | C7957 |
| 1 | 5 | 1 |
|
| |||
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral |
| Atozet | MK | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
Tablet 10 mg-20 mg | Oral |
| Atozet | MK | MP NP | C7957 |
| 30 | 5 | 30 |
|
| |
Tablet 10 mg-40 mg | Oral |
| Atozet | MK | MP NP | C7957 |
| 30 | 5 | 30 |
|
| |
Tablet 10 mg-80 mg | Oral |
| Atozet | MK | MP NP | C7957 |
| 30 | 5 | 30 |
|
| |
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | a | APO-Ezetimibe/Simvastatin 10/10 | TX | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | Vytorin | MK | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | Zeklen 10/10 mg | AF | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
| Tablet 10 mg-20 mg | Oral | a | APO-Ezetimibe/Simvastatin 10/20 | TX | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | Vytorin | MK | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
|
|
| a | Zeklen 10/20 mg | AF | MP NP | C7958 |
| 30 | 5 | 30 |
|
|
| Tablet 10 mg-40 mg | Oral | a | APO-Ezetimibe/Simvastatin 10/40 | TX | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | Vytorin | MK | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | Zeklen 10/40 mg | AF | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
| Tablet 10 mg-80 mg | Oral | a | APO-Ezetimibe/Simvastatin 10/80 | TX | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | Vytorin | MK | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
|
|
| a | Zeklen 10/80 mg | AF | MP NP | C7957 |
| 30 | 5 | 30 |
|
|
Famciclovir | Tablet 125 mg | Oral | a | APO-Famciclovir | TX | MP NP | C5937 |
| 40 | 1 | 40 |
|
|
a | Auro-Famciclovir 125 | DO | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
a | Ezovir | AF | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
a | Famciclovir-GA | ED | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
a | Famvir | HX | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
a | Favic 125 | RW | MP NP | C5937 |
| 40 | 1 | 40 |
|
| |||
Tablet 250 mg | Oral | a | APO-Famciclovir | TX | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |
a | Ezovir | AF | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | Famciclovir Sandoz | SZ | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | Famciclovir-GA | ED | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | Famvir | HX | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | Favic 250 | RW | MP NP | C5937 C5951 C5971 | P5937 | 20 | 1 | 20 |
|
| |||
a | APO-Famciclovir | TX | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Auro-Famciclovir 250 | DO | MP NP | C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Ezovir | AF | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famciclovir generichealth 250 | GQ | MP NP | C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famciclovir Sandoz | SZ | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famciclovir SCP 250 | CR | MP NP | C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famciclovir-GA | ED | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famlo | RA | MP NP | C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Famvir | HX | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | Favic 250 | RW | MP NP | C5937 C5951 C5971 | P5951 | 21 | 0 | 21 |
|
| |||
a | APO-Famciclovir | TX | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Auro-Famciclovir 250 | DO | MP NP | C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Ezovir | AF | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famciclovir FBM | FO | MP NP | C5971 |
| 56 | 5 | 56 |
|
| |||
a | Famciclovir generichealth 250 | GQ | MP NP | C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famciclovir Sandoz | SZ | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famciclovir SCP 250 | CR | MP NP | C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famciclovir-GA | ED | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famlo | RA | MP NP | C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Famvir | HX | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
a | Favic 250 | RW | MP NP | C5937 C5951 C5971 | P5971 | 56 | 5 | 56 |
|
| |||
Tablet 500 mg | Oral | a | APO-Famciclovir | TX | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |
a | Auro-Famciclovir 500 | DO | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |||
a | Famciclovir Sandoz | SZ | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |||
a | Famvir | HX | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |||
a | Favic 500 | RW | MP NP | C5943 C5947 C5948 C5949 C5954 | P5943 | 30 | 0 | 30 |
|
| |||
a | APO-Famciclovir | TX | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
a | Auro-Famciclovir 500 | DO | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
a | Ezovir | AF | MP NP | C5947 C5948 C5949 C5954 |
| 56 | 5 | 56 |
|
| |||
a | Famciclovir AN | EA | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
a | Famciclovir generichealth 500 | GQ | MP NP | C5947 C5948 C5949 C5954 |
| 56 | 5 | 56 |
|
| |||
a | Famciclovir Sandoz | SZ | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
a | Famciclovir-GA | ED | MP NP | C5947 C5948 C5949 C5954 |
| 56 | 5 | 56 |
|
| |||
a | Famvir | HX | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
a | Favic 500 | RW | MP NP | C5943 C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 | 56 |
|
| |||
Famotidine | Tablet 20 mg | Oral | a | Ausfam 20 | RW | MP NP |
|
| 60 | 5 | 60 |
|
|
a | Famotidine AN | EA | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Famotidine Sandoz | SZ | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | GenRx Famotidine | GX | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Tablet 40 mg | Oral | a | Ausfam 40 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Famotidine AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Famotidine Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | GenRx Famotidine | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Febuxostat | Tablet 80 mg | Oral |
| Adenuric | FK | MP NP | C5322 |
| 28 | 5 | 28 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | a | Felodur ER 2.5 mg | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Fendex ER | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Plendil ER | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 5 mg (extended release) | Oral | a | Felodil XR 5 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Felodur ER 5 mg | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Fendex ER | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Plendil ER | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 10 mg (extended release) | Oral | a | Felodil XR 10 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Felodur ER 10 mg | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Fendex ER | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Plendil ER | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Fenofibrate | Tablet 48 mg | Oral |
| Lipidil | GO | MP NP |
|
| 60 | 5 | 60 |
|
|
MP |
| P7640 | 60 | 11 | 60 |
|
| ||||||
Tablet 145 mg | Oral |
| Lipidil | GO | MP NP |
|
| 30 | 5 | 30 |
|
| |
MP |
| P7640 | 30 | 11 | 30 |
|
| ||||||
Fentanyl | Lozenge 200 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
|
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Lozenge 400 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Lozenge 600 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Lozenge 800 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Lozenge 1200 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Lozenge 1600 micrograms (as citrate) | Buccal |
| Actiq | TB | MP NP | C5904 C5915 | P5915 | 9 | 0 | 9 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Transdermal patch 1.28 mg | Transdermal |
| Denpax | AF | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
Transdermal patch 2.063 mg | Transdermal |
| Dutran 12 | EA | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Fenpatch 12 | ZP | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 2.1 mg | Transdermal | a | APO-Fentanyl | TX | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
a | Durogesic 12 | JC | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
a | Fentanyl Sandoz | SZ | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 2.55 mg | Transdermal |
| Denpax | AF | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
Transdermal patch 4.125 mg | Transdermal |
| Dutran 25 | EA | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Fenpatch 25 | ZP | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 4.2 mg | Transdermal |
| APO-Fentanyl | TX | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Durogesic 25 | JC | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
| Fentanyl Sandoz | SZ | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 5.10 mg | Transdermal |
| Denpax | AF | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
Transdermal patch 7.65 mg | Transdermal |
| Denpax | AF | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
Transdermal patch 8.25 mg | Transdermal |
| Dutran 50 | EA | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Fenpatch 50 | ZP | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 8.4 mg | Transdermal |
| APO-Fentanyl | TX | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Durogesic 50 | JC | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
| Fentanyl Sandoz | SZ | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 10.20 mg | Transdermal |
| Denpax | AF | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
Transdermal patch 12.375 mg | Transdermal |
| Dutran 75 | EA | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Fenpatch 75 | ZP | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 12.6 mg | Transdermal |
| APO-Fentanyl | TX | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Durogesic 75 | JC | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
| Fentanyl Sandoz | SZ | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 16.5 mg | Transdermal | a | Dutran 100 | EA | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
a | Fenpatch 100 | ZP | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Transdermal patch 16.8 mg | Transdermal |
| APO-Fentanyl | TX | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |
| Durogesic 100 | JC | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
| Fentanyl Sandoz | SZ | MP NP | C4952 |
| 5 | 0 | 5 |
|
| |||
Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal |
| Fentora | TB | MP NP | C6026 C6027 | P6026 | 8 | 0 | 4 |
|
| |
MP NP | C6026 C6027 | P6027 | 56 | 0 | 28 |
|
| ||||||
Tablet (sublingual) 100 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 20 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal |
| Fentora | TB | MP NP | C6026 C6027 | P6026 | 8 | 0 | 4 |
|
| |
MP NP | C6026 C6027 | P6027 | 56 | 0 | 28 |
|
| ||||||
Tablet (sublingual) 200 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 20 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Tablet (sublingual) 300 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 10 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Tablet (orally disintegrating) 400 micrograms (as citrate) | Buccal |
| Fentora | TB | MP NP | C6026 C6027 | P6026 | 8 | 0 | 4 |
|
| |
MP NP | C6026 C6027 | P6027 | 56 | 0 | 28 |
|
| ||||||
Tablet (sublingual) 400 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 10 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Tablet (orally disintegrating) 600 micrograms (as citrate) | Buccal |
| Fentora | TB | MP NP | C6026 C6027 | P6026 | 8 | 0 | 4 |
|
| |
MP NP | C6026 C6027 | P6027 | 56 | 0 | 28 |
|
| ||||||
Tablet (sublingual) 600 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 10 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Tablet (orally disintegrating) 800 micrograms (as citrate) | Buccal |
| Fentora | TB | MP NP | C6026 C6027 | P6026 | 8 | 0 | 4 |
|
| |
MP NP | C6026 C6027 | P6027 | 56 | 0 | 28 |
|
| ||||||
Tablet (sublingual) 800 micrograms (as citrate) | Sublingual |
| Abstral | FK | MP NP | C5904 C5915 | P5915 | 10 | 0 | 10 |
|
| |
MP NP | C5904 C5915 | P5904 | 60 | 0 | 30 |
|
| ||||||
Ferric carboxymaltose | Injection 500 mg (iron) in 10 mL | Injection |
| Ferinject | VL | MP NP |
|
| 2 | 1 | 1 |
|
|
Ferric derisomaltose | Injection 500 mg (iron) in 5 mL | Injection |
| Monofer | PF | MP NP |
|
| 2 | 1 | 1 |
|
|
Ferrous fumarate | Tablet 200 mg (equivalent to 65.7 mg iron) | Oral |
| Ferro-tab | AE | MP NP | C6812 |
| 60 | 1 | 60 |
|
|
Ferrous fumarate with folic acid | Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms | Oral |
| Ferro-f-tab | AE | MP NP | C6812 |
| 60 | 1 | 60 |
|
|
Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral |
| Ferro-Liquid | AE | MP NP |
|
| 1 | 2 | 1 |
|
|
Filgrastim | Injection 120 micrograms in 0.2 mL single use pre-filled syringe (Nivestim) | Injection |
| Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) |
Injection 300 micrograms in 0.5 mL single use pre-filled syringe (Neupogen) | Injection |
| Neupogen | AN | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 300 micrograms in 0.5 mL single use pre-filled syringe (Nivestim) | Injection |
| Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 300 micrograms in 0.5 mL single use pre-filled syringe (TevaGrastim) | Injection |
| TevaGrastim | TB | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 300 micrograms in 0.5 mL single use pre-filled syringe (Zarzio) | Injection |
| Zarzio | SZ | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 5 |
| D(100) | |
Injection 300 micrograms in 1 mL | Injection |
| Neupogen | AN | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 480 micrograms in 0.5 mL single use pre-filled syringe (Neupogen) | Injection |
| Neupogen | AN | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 480 micrograms in 0.5 mL single use pre-filled syringe (Nivestim) | Injection |
| Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 480 micrograms in 0.5 mL single use pre-filled syringe (Zarzio) | Injection |
| Zarzio | SZ | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 5 |
| D(100) | |
Injection 480 micrograms in 0.8 mL single use pre-filled syringe (TevaGrastim) | Injection |
| TevaGrastim | TB | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Injection 480 micrograms in 1.6 mL | Injection |
| Neupogen | AN | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 | 10 |
| D(100) | |
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral |
| Gilenya | NV | MP | C6868 C7732 |
| 28 | 5 | 28 |
|
|
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | a | Flecainide Sandoz | SZ | MP NP | C5550 C5584 |
| 60 | 5 | 60 |
|
|
a | Tambocor | IL | MP NP | C5550 C5584 |
| 60 | 5 | 60 |
|
| |||
Tablet containing flecainide acetate 100 mg | Oral | a | Flecainide Sandoz | SZ | MP NP | C5550 C5584 |
| 60 | 5 | 60 |
|
| |
a | Flecatab | AF | MP NP | C5550 C5584 |
| 60 | 5 | 60 |
|
| |||
a | Tambocor | IL | MP NP | C5550 C5584 |
| 60 | 5 | 60 |
|
| |||
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | a | APO-Flucloxacillin | TX | MP NP MW | C5414 |
| 24 | 0 | 24 |
|
|
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
a | Flopen | AS | MP NP MW | C5414 |
| 24 | 0 | 24 |
|
| |||
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
a | Staphylex 250 | AF | MP NP MW | C5414 |
| 24 | 0 | 24 |
|
| |||
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
Capsule 500 mg (as sodium monohydrate) | Oral | a | APO-Flucloxacillin | TX | MP | C5414 C6169 | P5414 | 24 | 0 | 24 |
|
| |
NP MW | C5414 |
| 24 | 0 | 24 |
|
| ||||||
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
a | Flopen | AS | MP | C5414 C6169 | P5414 | 24 | 0 | 24 |
|
| |||
NP MW | C5414 |
| 24 | 0 | 24 |
|
| ||||||
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
a | Staphylex 500 | AF | MP | C5414 C6169 | P5414 | 24 | 0 | 24 |
|
| |||
NP MW | C5414 |
| 24 | 0 | 24 |
|
| ||||||
PDP | C5298 |
| 24 | 0 | 24 |
|
| ||||||
a | APO-Flucloxacillin | TX | MP | C5414 C6169 | P6169 | 48 | 1 | 24 |
|
| |||
a | Flopen | AS | MP | C5414 C6169 | P6169 | 48 | 1 | 24 |
|
| |||
a | Staphylex 500 | AF | MP | C5414 C6169 | P6169 | 48 | 1 | 24 |
|
| |||
Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
| Flucil | LN | PDP | C5298 |
| 1 | 0 | 1 |
|
| |
MP NP | C5297 |
| 1 | 1 | 1 |
|
| ||||||
Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
| Flucil | LN | PDP | C5298 |
| 1 | 0 | 1 |
|
| |
MP NP | C5297 |
| 1 | 1 | 1 |
|
| ||||||
Powder for injection 1 g (as sodium monohydrate) | Injection | a | Flubiclox | JU | PDP |
|
| 5 | 0 | 10 |
|
| |
a | Flucil | AS | PDP |
|
| 5 | 0 | 5 |
|
| |||
a | Hospira Pty Limited | PF | PDP |
|
| 5 | 0 | 10 |
|
| |||
a | Flubiclox | JU | MP NP |
|
| 5 | 1 | 10 |
|
| |||
a | Flucil | AS | MP NP |
|
| 5 | 1 | 5 |
|
| |||
a | Hospira Pty Limited | PF | MP NP |
|
| 5 | 1 | 10 |
|
| |||
Fluconazole | Capsule 50 mg | Oral | a | Diflucan | PF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
|
a | Dizole 50 | AF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Fluconazole Sandoz | SZ | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Ozole | RA | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
Capsule 100 mg | Oral | a | Diflucan | PF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |
a | Dizole 100 | AF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Fluconazole Sandoz | SZ | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Ozole | RA | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
Capsule 200 mg | Oral | a | APO-Fluconazole | TX | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |
a | Diflucan | PF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Dizole 200 | AF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Fluconazole APOTEX | GX | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Fluconazole Sandoz | SZ | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Fluzole 200 | RW | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
a | Ozole | RA | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 28 | 5 | 28 |
|
| |||
Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral |
| Diflucan | PF | MP NP | C6006 C6031 C6032 C6045 C6046 C7934 |
| 1 | 0 | 1 |
|
| |
Solution for I.V. infusion 100 mg in 50 mL | Injection |
| Fluconazole Sandoz | SZ | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 7 | 0 | 1 |
|
| |
Solution for I.V. infusion 200 mg in 100 mL | Injection | a | Fluconazole Alphapharm | AF | MP NP | C6956 C6965 C6969 C6974 C6978 C7897 |
| 7 | 0 | 1 |
|
| |
a | Fluconazole Sandoz | SZ | MP NP | C6956 C6965 C6969 C6974 C6978 C7897 |
| 7 | 0 | 1 |
|
| |||
Solution for I.V. infusion 400 mg in 200 mL | Injection |
| Fluconazole Alphapharm | AF | MP NP | C5978 C5989 C6002 C6023 C6030 C7898 |
| 1 | 0 | 1 |
|
| |
Fludarabine | Powder for I.V. injection containing fludarabine phosphate 50 mg | Injection |
| Fludarabine ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) |
| Fludarabine AMNEAL | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL | Injection |
| Fludarabine Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 5 |
| PB(100) | |
Tablet containing fludarabine phosphate 10 mg | Oral |
| Fludara | GZ | MP |
|
| 20 | 5 | 20 |
|
| |
Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral |
| Florinef | QA | MP NP |
|
| 200 | 1 | 100 |
|
|
Fluorometholone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| Flucon | NV | AO |
|
| 1 | 0 | 1 |
|
|
| FML Liquifilm | AG | AO |
|
| 1 | 0 | 1 |
|
| |||
| Flucon | NV | MP NP |
|
| 1 | 5 | 1 |
|
| |||
| FML Liquifilm | AG | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL | Application to the eye |
| Flarex | NV | AO |
|
| 1 | 0 | 1 |
|
| |
MP NP |
|
| 1 | 2 | 1 |
|
| ||||||
Fluorouracil | Injection 500 mg in 10 mL | Injection |
| DBL Fluorouracil Injection BP | PF | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 5 |
| D(100) |
| Fluorouracil Accord | OC | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Injection 1000 mg in 20 mL | Injection |
| Fluorouracil Accord | OC | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
|
|
| Fluorouracil Ebewe | SZ | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Injection 2500 mg in 50 mL | Injection |
| DBL Fluorouracil Injection BP | PF | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Fluorouracil Accord | OC | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Fluorouracil Ebewe | SZ | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Injection 5000 mg in 100 mL | Injection |
| Fluorouracil Accord | OC | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
|
|
| Fluorouracil Ebewe | SZ | MP | C6266 C6297 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | a | APO-Fluoxetine | TX | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
|
a | Auscap Aspen | RW | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Blooms the Chemist Fluoxetine | IB | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Chem mart Fluoxetine | CH | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | FLUOTEX | RF | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Fluoxetine AN | EA | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Fluoxetine generichealth | GQ | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Fluoxetine Sandoz | SZ | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Fluoxetine-GA | ED | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | GenRx Fluoxetine | GX | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Lovan | AL | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Prozac 20 | LY | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Terry White Chemists Fluoxetine | TW | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Zactin | AF | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
Tablet, dispersible, 20 mg (as hydrochloride) | Oral | a | Lovan 20 Tab | AL | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |
a | Prozac Tab | LY | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
a | Zactin Tablet | AF | MP NP | C4755 C6277 |
| 28 | 5 | 28 |
|
| |||
Flupentixol decanoate | Oily I.M. injection 20 mg in 1 mL | Injection |
| Fluanxol Depot | LU | MP NP |
|
| 5 | 0 | 5 |
|
|
Oily I.M. injection 100 mg in 1 mL | Injection |
| Fluanxol Concentrated Depot | LU | MP NP |
|
| 5 | 0 | 5 |
|
| |
Flutamide | Tablet 250 mg | Oral |
| Flutamin | AF | MP NP | C5816 |
| 100 | 5 | 100 |
|
|
Fluticasone | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth |
| Flixotide Junior | GK | MP NP |
|
| 1 | 5 | 1 |
|
|
Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | a | Flixotide | GK | MP NP |
|
| 1 | 5 | 1 |
|
| |
a | Fluticasone Cipla Inhaler | LR | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | a | Flixotide | GK | MP NP |
|
| 1 | 1 | 1 |
|
| |
a | Fluticasone Cipla Inhaler | LR | MP NP |
|
| 1 | 1 | 1 |
|
| |||
Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth |
| Flixotide Junior Accuhaler | GK | MP NP |
|
| 1 | 5 | 1 |
|
| |
Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth |
| Flixotide Accuhaler | GK | MP NP |
|
| 1 | 5 | 1 |
|
| |
Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth |
| Flixotide Accuhaler | GK | MP NP |
|
| 1 | 1 | 1 |
|
| |
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Trelegy Ellipta 100/62.5/25 | GK | MP NP | C7651 |
| 1 | 5 | 1 |
|
|
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Breo Ellipta 100/25 | GK | MP NP | C4689 C4711 |
| 1 | 5 | 1 |
|
|
Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Breo Ellipta 200/25 | GK | MP NP | C4731 |
| 1 | 5 | 1 |
|
| |
Fluticasone with formoterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
| flutiform 50/5 | MF | MP NP | C4395 |
| 1 | 5 | 1 |
|
|
Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
| flutiform 125/5 | MF | MP NP | C4395 |
| 1 | 5 | 1 |
|
| |
Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses | Inhalation by mouth |
| flutiform 250/10 | MF | MP NP | C4395 |
| 1 | 5 | 1 |
|
| |
Fluticasone with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth |
| Seretide MDI 50/25 | GK | MP NP | C4930 |
| 1 | 5 | 1 |
|
|
Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | a | Fluticasone + Salmeterol Cipla 125/25 | LR | MP NP | C4930 |
| 1 | 5 | 1 |
|
| |
a | SalplusF Inhaler 125/25 | YC | MP NP | C4930 |
| 1 | 5 | 1 |
|
| |||
a | Seretide MDI 125/25 | GK | MP NP | C4930 |
| 1 | 5 | 1 |
|
| |||
Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | a | Fluticasone + Salmeterol Cipla 250/25 | LR | MP NP | C4689 C4930 |
| 1 | 5 | 1 |
|
| |
a | SalplusF Inhaler 250/25 | YC | MP NP | C4689 C4930 |
| 1 | 5 | 1 |
|
| |||
a | Seretide MDI 250/25 | GK | MP NP | C4689 C4930 |
| 1 | 5 | 1 |
|
| |||
Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Seretide Accuhaler 100/50 | GK | MP NP | C4930 |
| 1 | 5 | 1 |
|
| |
Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Seretide Accuhaler 250/50 | GK | MP NP | C4930 |
| 1 | 5 | 1 |
|
| |
Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Seretide Accuhaler 500/50 | GK | MP NP | C4689 C4930 |
| 1 | 5 | 1 |
|
| |
Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | Oral |
| Lescol XL | NV | MP NP |
|
| 28 | 5 | 28 |
|
|
MP |
| P7598 | 28 | 11 | 28 |
|
| ||||||
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | a | APO-Fluvoxamine | TX | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
|
a | Faverin 50 | RW | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Fluvoxamine AN | ED | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Fluvoxamine GA | EA | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Luvox | GO | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Movox 50 | AL | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Voxam | SZ | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
Tablet containing fluvoxamine maleate 100 mg | Oral | a | APO-Fluvoxamine | TX | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |
a | Faverin 100 | RW | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Fluvoxamine AN | ED | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Fluvoxamine GA | EA | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Luvox | GO | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Movox 100 | AF | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
a | Voxam | SZ | MP NP | C4755 C6277 |
| 30 | 5 | 30 |
|
| |||
Folic acid | Tablet 500 micrograms | Oral | a | Foltabs 500 | PP | MP NP | C5824 |
| 200 | 0 | 100 |
|
|
a | Megafol 0.5 | AF | MP NP | C5824 |
| 200 | 0 | 100 |
|
| |||
Tablet 5 mg | Oral |
| Megafol 5 | AF | MP NP | C5820 |
| 200 | 1 | 100 |
|
| |
Folinic acid | Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection | a | Leucovorin Calcium (Hospira Pty Limited) | PF | MP |
|
| 10 | 2 | 1 |
|
|
a | Leucovorin Calcium (Pfizer Australia Pty Ltd) | PF | MP |
|
| 10 | 2 | 10 |
|
| |||
Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL | Injection | a | Calcium Folinate Ebewe | SZ | MP |
|
| 10 | 1 | 1 |
|
| |
a | Leucovorin Calcium (Pfizer Australia Pty Ltd) | PF | MP |
|
| 10 | 1 | 10 |
|
| |||
Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL | Injection | a | Calcium Folinate Ebewe | SZ | MP |
|
| 4 | 1 | 1 |
|
| |
a | Leucovorin Calcium (Hospira Pty Limited) | PF | MP |
|
| 4 | 1 | 1 |
|
| |||
Injection containing calcium folinate equivalent to 1000 mg folinic acid in 100 mL | Injection |
| Calcium Folinate Ebewe | SZ | MP |
|
| 1 | 1 | 1 |
|
| |
Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral |
| Leucovorin Calcium (Hospira Pty Limited) | PF | MP | C5938 |
| 10 | 0 | 10 |
|
| |
MP | C5973 |
| 10 | 0 | 10 |
| C(100) | ||||||
Follitropin alfa | Injection 75 I.U. in 0.125 mL pre-filled pen | Injection |
| Bemfola | FX | MP | C5027 |
| 15 | 0 | 5 |
| C(100) |
MP | C6257 C6321 |
| 15 | 1 | 5 |
|
| ||||||
Injection 150 I.U. in 0.25 mL pre-filled pen | Injection |
| Bemfola | FX | MP | C5027 |
| 15 | 0 | 5 |
| C(100) | |
MP | C6257 C6321 |
| 15 | 1 | 5 |
|
| ||||||
Injection 225 I.U. in 0.375 mL pre-filled pen | Injection |
| Bemfola | FX | MP | C5027 |
| 15 | 0 | 5 |
| C(100) | |
MP | C6257 C6321 |
| 15 | 1 | 5 |
|
| ||||||
Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection |
| Gonal-f Pen | SG | MP | C5027 |
| 2 | 0 | 1 |
| C(100) | |
MP | C6257 C6321 |
| 3 | 5 | 1 |
|
| ||||||
Injection 300 I.U. in 0.5 mL pre-filled pen | Injection |
| Bemfola | FX | MP | C5027 |
| 15 | 0 | 5 |
| PB(100) | |
Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection |
| Gonal-f Pen | SG | MP | C5027 |
| 2 | 0 | 1 |
| C(100) | |
MP | C6257 C6321 |
| 3 | 5 | 1 |
|
| ||||||
Injection 450 I.U. in 0.75 mL pre-filled pen | Injection |
| Bemfola | FX | MP | C5027 |
| 15 | 0 | 5 |
| PB(100) | |
Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection |
| Gonal-f Pen | SG | MP | C6257 C6321 |
| 2 | 5 | 1 |
|
| |
MP | C5027 |
| 5 | 0 | 1 |
| C(100) | ||||||
Follitropin alfa with lutropin alfa | Injection 900 I.U. - 450 I.U. in 1.44 mL multi-dose cartridge | Injection |
| Pergoveris | SG | MP | C5250 |
| 2 | 0 | 1 |
| D(100) |
| Powder for injection 150 I.U.-75 I.U. with solvent | Injection |
| Pergoveris | SG | MP | C5250 |
| 14 | 0 | 1 |
| D(100) |
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection |
| Puregon 300 IU/0.36 mL | MK | MP | C5027 |
| 2 | 0 | 1 |
| C(100) |
MP | C6257 C6321 |
| 3 | 5 | 1 |
|
| ||||||
Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection |
| Puregon 600 IU/0.72 mL | MK | MP | C6257 C6321 |
| 2 | 5 | 1 |
|
| |
MP | C5027 |
| 4 | 0 | 1 |
| C(100) | ||||||
Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection |
| Puregon 900 IU/1.08 mL | MK | MP | C6257 C6321 |
| 2 | 5 | 1 |
|
| |
MP | C5027 |
| 5 | 0 | 1 |
| C(100) | ||||||
Follitropin delta | Injection 12 micrograms in 0.36 mL pre-filled multi-dose pen | Injection |
| Rekovelle | FP | MP | C5027 |
| 5 | 0 | 1 |
| D(100) |
| Injection 36 micrograms in 1.08 mL pre-filled multi-dose pen | Injection |
| Rekovelle | FP | MP | C5027 |
| 5 | 0 | 1 |
| D(100) |
| Injection 72 micrograms in 2.16 mL pre-filled multi-dose pen | Injection |
| Rekovelle | FP | MP | C5027 |
| 4 | 0 | 1 |
| D(100) |
Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre-filled syringe | Injection |
| Arixtra | AS | MP NP | C5781 C5808 |
| 7 | 0 | 2 |
|
|
Formoterol | Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth |
| Foradile | SZ | MP NP | C6355 |
| 60 | 5 | 60 |
|
|
Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth |
| Oxis Turbuhaler | AP | MP NP | C6355 |
| 1 | 5 | 1 |
|
| |
Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth |
| Oxis Turbuhaler | AP | MP NP | C6355 |
| 1 | 5 | 1 |
|
| |
Fosamprenavir | Tablet 700 mg (as calcium) | Oral |
| Telzir | VI | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) |
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection |
| Emend IV | MK | MP NP | C6852 C6886 C6887 C6891 |
| 1 | 5 | 1 |
|
|
Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral | a | APO-Fosinopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Fosipril 10 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Monace 10 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing fosinopril sodium 20 mg | Oral | a | APO-Fosinopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Fosipril 20 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Monace 20 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Fosinopril with hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | a | APO-Fosinopril HCTZ 20/12.5 | TX | MP NP | C4389 |
| 30 | 5 | 30 |
|
|
a | Fosetic 20/12.5 | ZP | MP NP | C4389 |
| 30 | 5 | 30 |
|
| |||
a | Fosinopril/HCT Actavis 20/12.5 | EA | MP NP | C4389 |
| 30 | 5 | 30 |
|
| |||
Fotemustine | Powder for injection 208 mg with solvent | Injection |
| Muphoran | SE | MP | C6288 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear |
| Soframycin | SW | MP NP MW AO |
|
| 1 | 2 | 1 |
|
|
Furosemide | Injection 20 mg in 2 mL | Injection | a | Frusemide Sandoz | SZ | MP NP |
|
| 5 | 0 | 5 |
|
|
a | Frusemide-Claris | BX | MP NP |
|
| 5 | 0 | 5 |
|
| |||
a | Lasix | SW | MP NP |
|
| 5 | 0 | 5 |
|
| |||
Oral solution 10 mg per mL, 30 mL | Oral |
| Lasix | SW | MP NP |
|
| 1 | 3 | 1 |
|
| |
Tablet 20 mg | Oral | a | Lasix-M | SW | MP NP |
|
| 100 | 1 | 50 |
|
| |
a | Urex-M | RW | MP NP |
|
| 100 | 1 | 50 |
|
| |||
a | APO-Frusemide | TX | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Chem mart Frusemide | CH | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | FUROSEMIDE AN | EA | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Terry White Chemists Frusemide | TW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
Tablet 40 mg | Oral | a | APO-Frusemide | TX | MP NP |
|
| 100 | 1 | 100 |
|
| |
a | Chem mart Frusemide | CH | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Frusax | ER | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Frusemide Sandoz | SZ | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | FUROSEMIDE AN | EA | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Lasix | SW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Terry White Chemists Frusemide | TW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Uremide | AF | MP NP |
|
| 100 | 1 | 100 |
|
| |||
| Urex | RW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
Tablet 500 mg | Oral |
| Urex-Forte | RW | MP NP |
|
| 50 | 3 | 50 |
|
| |
Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral |
| Fucidin | LO | MP | C4963 C6133 | P4963 | 36 | 1 | 36 |
|
|
MP | C4963 C6133 | P6133 | 72 | 1 | 36 |
|
| ||||||
Gabapentin | Capsule 100 mg | Oral | a | APO-Gabapentin | TX | MP NP | C4928 |
| 100 | 5 | 100 |
|
|
a | Gabacor | CR | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin APOTEX | TY | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Aspen 100 | RW | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Neurontin | PF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Nupentin 100 | AF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
Capsule 300 mg | Oral | a | APO-Gabapentin | TX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |
a | Gabacor | CR | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin AN | EA | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin APOTEX | TY | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Aspen 300 | RW | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin generichealth | HQ | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Sandoz | SZ | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GenRx Gabapentin | GX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Neurontin | PF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Nupentin 300 | AF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
Capsule 400 mg | Oral | a | APO-Gabapentin | TX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |
a | Gabacor | CR | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin AN | EA | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin APOTEX | TY | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Aspen 400 | RW | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin generichealth | HQ | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Sandoz | SZ | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GenRx Gabapentin | GX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Neurontin | PF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Nupentin 400 | AF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
Tablet 600 mg | Oral | a | APO-Gabapentin | TX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |
a | Gabapentin AN | EA | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Aspen 600 | RW | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GenRx Gabapentin | GX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Neurontin | PF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Nupentin Tabs | AF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Pharmacor Gabapentin 600 | CR | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
Tablet 800 mg | Oral | a | APO-Gabapentin | TX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |
a | Gabapentin AN | EA | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Gabapentin Aspen 800 | RW | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | GenRx Gabapentin | GX | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Neurontin | PF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Nupentin Tabs | AF | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
a | Pharmacor Gabapentin 800 | CR | MP NP | C4928 |
| 100 | 5 | 100 |
|
| |||
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | a | APO-Galantamine MR | TX | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
|
a | Galantamine AN SR | EA | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Galantyl | AF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Gamine XR | RW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Reminyl | JC | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | a | APO-Galantamine MR | TX | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |
a | Galantamine AN SR | EA | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Galantyl | AF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Gamine XR | RW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Reminyl | JC | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | a | APO-Galantamine MR | TX | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |
a | Galantamine AN SR | EA | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Galantyl | AF | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Gamine XR | RW | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
a | Reminyl | JC | MP NP | C4219 C4220 C4224 |
| 28 | 5 | 28 |
|
| |||
Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | a | Cymevene | RO | MP | C4972 C4990 C4999 C5000 C5025 |
| 10 | 1 | 5 |
| D(100) |
|
|
| a | GANCICLOVIR SXP | HN | MP | C4972 C4990 C4999 C5000 C5025 |
| 10 | 1 | 5 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection |
| Orgalutran | MK | MP | C5046 |
| 10 | 0 | 1 |
| D(100) |
MP | C5046 |
| 10 | 0 | 5 |
| D(100) | ||||||
Gefitinib | Tablet 250 mg | Oral |
| Iressa | AP | MP | C4473 C7447 |
| 30 | 3 | 30 |
|
|
Gemcitabine | Solution for injection 1 g (as hydrochloride) in 26.3 mL | Injection |
| DBL Gemcitabine Injection | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution for injection 2 g (as hydrochloride) in 52.6 mL | Injection |
| DBL Gemcitabine Injection | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Gemfibrozil | Tablet 600 mg | Oral | a | Ausgem | RW | MP NP |
|
| 60 | 5 | 60 |
|
|
a | Lipigem | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Ausgem | RW | MP |
| P7640 | 60 | 11 | 60 |
|
| |||
a | Lipigem | AF | MP |
| P7640 | 60 | 11 | 60 |
|
| |||
Gentamicin | Eye drops 3 mg (as sulfate) per mL, 5 mL | Application to the eye |
| Genoptic | AG | MP | C5451 C5483 C5499 |
| 1 | 2 | 1 |
|
|
AO | C5476 C5477 |
| 1 | 2 | 1 |
|
| ||||||
Injection 80 mg (as sulfate) in 2 mL | Injection |
| Pfizer Australia Pty Ltd | PF | MP NP |
|
| 10 | 1 | 10 |
|
| |
Glatiramer | Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe | Injection |
| Copaxone | TB | MP | C6860 C7695 |
| 28 | 5 | 28 |
|
|
Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe | Injection |
| Copaxone | TB | MP | C6860 C7695 |
| 12 | 5 | 12 |
|
| |
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral |
| Maviret | VE | MP NP | C7593 C7594 C7615 | P7593 | 84 | 1 | 84 |
|
|
|
|
|
|
|
| MP NP | C7593 C7594 C7615 | P7615 | 84 | 2 | 84 |
|
|
|
|
|
|
|
| MP NP | C7593 C7594 C7615 | P7594 | 84 | 3 | 84 |
|
|
Glibenclamide | Tablet 5 mg | Oral |
| Daonil | SW | MP NP |
|
| 100 | 5 | 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | a | APO-Gliclazide MR | TX | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Glyade MR | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet 60 mg (modified release) | Oral | a | ARDIX GLICLAZIDE 60mg MR | RX | MP NP |
|
| 60 | 5 | 60 |
|
| |
a | Diamicron 60mg MR | SE | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Tablet 80 mg | Oral | a | APO-Gliclazide | TX | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | GenRx Gliclazide | GX | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Glyade | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Nidem | RW | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Glimepiride | Tablet 1 mg | Oral | a | Amaryl | SW | MP NP |
|
| 30 | 5 | 30 |
|
|
a | APO-Glimepiride | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Aylide 1 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Diapride 1 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Dimirel | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 2 mg | Oral | a | Amaryl | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | APO-Glimepiride | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Aylide 2 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Diapride 2 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Dimirel | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 3 mg | Oral | a | Amaryl | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | APO-Glimepiride | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Aylide 3 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Diapride 3 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Dimirel | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 4 mg | Oral | a | Amaryl | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | APO-Glimepiride | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Aylide 4 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Diapride 4 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Dimirel | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Glipizide | Tablet 5 mg | Oral | a | Melizide | AF | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Minidiab | PF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection |
| GlucaGen Hypokit | NO | PDP |
|
| 1 | 0 | 1 |
|
|
MP NP |
|
| 1 | 1 | 1 |
|
| ||||||
Glucose and ketone indicator-urine | Test strips, 50 (Keto-Diastix) | For external use |
| Keto-Diastix | DX | MP NP | C5852 |
| 2 | 2 | 1 |
|
|
Glucose indicator-urine | Test strips, 50 (Diastix) | For external use |
| Diastix | DX | MP NP | C5852 |
| 2 | 2 | 1 |
|
|
Glyceryl trinitrate | Transdermal patch 18 mg | Transdermal |
| Minitran 5 | IL | MP NP |
|
| 30 | 5 | 30 |
|
|
Transdermal patch 25 mg | Transdermal |
| Transiderm-Nitro 25 | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |
Transdermal patch 36 mg | Transdermal |
| Minitran 10 | IL | MP NP |
|
| 30 | 5 | 30 |
|
| |
Transdermal patch 50 mg | Transdermal |
| Transiderm-Nitro 50 | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |
Transdermal patch 54 mg | Transdermal |
| Minitran 15 | IL | MP NP |
|
| 30 | 5 | 30 |
|
| |
Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
| Nitrolingual Pumpspray | SW | MP NP |
|
| 1 | 5 | 1 |
|
| |
Tablets 300 micrograms, 100 | Buccal/sublingual |
| Nitrostat | PF | PDP |
|
| 1 | 0 | 1 |
|
| |
MP NP |
|
| 1 | 5 | 1 |
|
| ||||||
Tablets 600 micrograms, 100 | Buccal/sublingual | a | Anginine Stabilised | RW | PDP |
|
| 1 | 0 | 1 |
|
| |
a | Lycinate | RF | PDP |
|
| 1 | 0 | 1 |
|
| |||
| Nitrostat | PF | PDP |
|
| 1 | 0 | 1 |
|
| |||
a | Anginine Stabilised | RW | MP NP |
|
| 1 | 5 | 1 |
|
| |||
a | Lycinate | RF | MP NP |
|
| 1 | 5 | 1 |
|
| |||
| Nitrostat | PF | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Glycine with carbohydrate | Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500) | Oral |
| Glycine500 | VF | MP NP | C4704 |
| 4 | 5 | 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 7 (Camino Pro Complete) | Oral |
| Camino Pro Complete | QH | MP NP | C4295 |
| 14 | 5 | 1 |
|
|
Bars 81 g, 14 (Tylactin Complete) | Oral |
| Tylactin Complete | QH | MP NP | C5533 |
| 8 | 5 | 1 |
|
| |
Oral liquid 250 mL, 30 (PKU Glytactin RTD 15) | Oral |
| PKU Glytactin RTD 15 | QH | MP NP | C5012 |
| 4 | 5 | 1 |
|
| |
Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite) | Oral |
| PKU Glytactin RTD 15 Lite | QH | MP NP | C5012 |
| 4 | 5 | 1 |
|
| |
Sachets containing oral powder 49 g, 30 (Camino Pro Bettermilk) | Oral |
| Camino Pro Bettermilk | QH | MP NP | C4295 |
| 4 | 5 | 1 |
|
| |
Oral liquid 250 mL, 30 (Tylactin RTD) | Oral |
| Tylactin RTD | QH | MP NP | C5533 |
| 4 | 5 | 1 |
|
| |
Sachets containing oral powder 16 g, 60 (PKU Build 10) | Oral |
| PKU Build 10 | QH | MP NP | C4295 |
| 2 | 5 | 1 |
|
| |
Sachets containing oral powder 20 g, 60 (PKU Restore) | Oral |
| PKU Restore | QH | MP NP | C4295 |
| 5 | 5 | 1 |
|
| |
Sachets containing oral powder 32 g, 30 (PKU Build 20) | Oral |
| PKU Build 20 | QH | MP NP | C4295 |
| 4 | 5 | 1 |
|
| |
Sachets containing oral powder 51 g, 30 (PKU Bettermilk Lite) | Oral |
| PKU Bettermilk Lite | QH | MP NP | C4295 |
| 4 | 5 | 1 |
|
| |
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Sachets containing oral powder 27 g, 30 (PKU Sphere15) | Oral |
| PKU Sphere15 | VF | MP NP | C4295 |
| 4 | 5 | 1 |
|
|
Sachets containing oral powder 35 g, 30 (PKU Sphere20) | Oral |
| PKU Sphere20 | VF | MP NP | C4295 |
| 4 | 5 | 1 |
|
| |
Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
| seebri breezhaler | NV | MP NP | C4516 |
| 30 | 5 | 30 |
|
|
Golimumab | Injection 50 mg in 0.5 mL single use pre-filled pen | Injection |
| Simponi | JC | MP | C4845 C4851 C6437 C6439 C6445 C8041 C8059 C8060 C8073 C8074 C8155 C8201 C8223 C8224 C8225 C8229 C8641 C8642 C8710 C8713 C8729 C8741 | P4851 P6437 P6445 P8059 P8060 P8073 P8201 P8223 P8229 P8710 P8713 P8729 P8741 | 1 | 3 | 1 |
|
|
MP | C4845 C4851 C6437 C6439 C6445 C8041 C8059 C8060 C8073 C8074 C8155 C8201 C8223 C8224 C8225 C8229 C8641 C8642 C8710 C8713 C8729 C8741 | P4845 P6439 P8041 P8074 P8155 P8224 P8225 P8641 P8642 | 1 | 5 | 1 |
|
| ||||||
Injection 50 mg in 0.5 mL single use pre-filled syringe | Injection |
| Simponi | JC | MP | C4845 C4851 C6437 C6439 C6445 C8041 C8059 C8060 C8073 C8074 C8155 C8201 C8223 C8224 C8225 C8229 C8641 C8642 C8710 C8713 C8729 C8741 | P4851 P6437 P6445 P8059 P8060 P8073 P8201 P8223 P8229 P8710 P8713 P8729 P8741 | 1 | 3 | 1 |
|
| |
MP | C4845 C4851 C6437 C6439 C6445 C8041 C8059 C8060 C8073 C8074 C8155 C8201 C8223 C8224 C8225 C8229 C8641 C8642 C8710 C8713 C8729 C8741 | P4845 P6439 P8041 P8074 P8155 P8224 P8225 P8641 P8642 | 1 | 5 | 1 |
|
| ||||||
Injection 100 mg in 1 mL single use pre-filled pen | Injection |
| Simponi | JC | MP | C7666 C7671 C7684 C7685 C7827 C7853 | P7684 | 1 | 1 | 1 |
|
| |
|
|
|
|
| MP | C7666 C7671 C7684 C7685 C7827 C7853 | P7666 P7671 P7685 | 1 | 5 | 1 |
|
| |
|
|
|
|
| MP | C7666 C7671 C7684 C7685 C7827 C7853 | P7827 P7853 | 3 | 0 | 1 |
|
| |
Goserelin | Subcutaneous implant 3.6 mg (as acetate) in pre-filled injection syringe | Implantation |
| Zoladex Implant | AP | MP | C4890 C4892 C5437 C7164 |
| 1 | 5 | 1 |
|
|
Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre-filled injection syringe | Implantation |
| Zoladex 10.8 Implant | AP | MP | C4890 |
| 1 | 1 | 1 |
|
| |
Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
| ZolaCos CP 3.6/50 | AP | MP | C4895 |
| 1 | 5 | 1 |
|
|
Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
| ZolaCos CP 10.8/50(28) | AP | MP | C4895 |
| 1 | 0 | 1 |
|
| |
Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral |
| ZolaCos CP 10.8/50(84) | AP | MP | C4895 |
| 1 | 1 | 1 |
|
| |
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | a | Granisetron Kabi | PK | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
|
MP | C4139 |
| 1 | 0 | 1 |
| C(100) | ||||||
a | Granisetron-AFT | AE | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
| |||
MP | C4139 |
| 1 | 0 | 1 |
| C(100) | ||||||
a | Kytril | IX | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
| |||
MP | C4139 |
| 1 | 0 | 1 |
| C(100) | ||||||
Tablet 2 mg (as hydrochloride) | Oral |
| Kytril | IX | MP NP | C4102 C4118 | P4118 | 2 | 0 | 1 |
|
| |
MP | C4139 |
| 2 | 0 | 1 |
| C(100) | ||||||
MP NP | C4102 C4118 | P4102 | 5 | 1 | 5 |
|
| ||||||
Grazoprevir with elbasvir | Tablet containing grazoprevir 100 mg with elbasvir 50 mg | Oral |
| Zepatier | MK | MP NP | C5969 C6625 | P5969 | 28 | 2 | 28 |
|
|
MP NP | C5969 C6625 | P6625 | 28 | 3 | 28 |
|
| ||||||
Griseofulvin | Tablet 125 mg | Oral |
| Grisovin | QA | MP NP |
|
| 100 | 2 | 100 |
|
|
Tablet 500 mg | Oral |
| Grisovin 500 | QA | MP NP |
|
| 28 | 2 | 28 |
|
| |
Guanfacine | Tablet 1 mg (as hydrochloride) | Oral |
| Intuniv | ZI | MP | C8544 C8564 C8585 |
| 28 | 5 | 28 |
|
|
| Tablet 2 mg (as hydrochloride) | Oral |
| Intuniv | ZI | MP | C8544 C8564 C8585 |
| 28 | 5 | 28 |
|
|
| Tablet 3 mg (as hydrochloride) | Oral |
| Intuniv | ZI | MP | C8544 C8564 C8585 |
| 28 | 5 | 28 |
|
|
| Tablet 4 mg (as hydrochloride) | Oral |
| Intuniv | ZI | MP | C8544 C8564 C8585 |
| 28 | 5 | 28 |
|
|
Guselkumab | Injection 100 mg in 1 mL single use pre-filled syringe | Injection |
| Tremfya | JC | MP | C8442 C8443 C8477 C8496 C8497 C8498 C8506 C8518 C8765 C8766 |
| 1 | 2 | 1 |
|
|
Haloperidol | Injection 5 mg in 1 mL | Injection |
| Serenace | QA | MP NP |
|
| 10 | 0 | 10 |
|
|
Oral solution 2 mg per mL, 100 mL | Oral |
| Serenace | QA | MP NP |
|
| 1 | 5 | 1 |
|
| |
Tablet 500 micrograms | Oral |
| Serenace | QA | MP NP |
|
| 100 | 5 | 100 |
|
| |
Tablet 1.5 mg | Oral |
| Serenace | QA | MP NP |
|
| 100 | 5 | 100 |
|
| |
Tablet 5 mg | Oral |
| Serenace | QA | MP NP |
|
| 50 | 5 | 50 |
|
| |
Haloperidol decanoate | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection |
| Haldol decanoate | JC | MP NP |
|
| 5 | 0 | 5 |
|
|
I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection |
| Haldol decanoate | JC | MP NP |
|
| 5 | 0 | 5 |
|
| |
Heparin | Injection 5,000 units (as sodium) in 0.2 mL | Injection |
| Hospira Pty Limited | PF | MP NP |
|
| 5 | 5 | 5 |
|
|
Injection (preservative-free) 5,000 I.U. (as sodium) in 5 mL | Injection |
| Pfizer Australia Pty Ltd | PF | MP NP |
|
| 50 | 5 | 50 |
|
| |
Injection 35,000 units (as sodium) in 35 mL | Injection |
| Hospira Pty Limited | PF | MP NP |
|
| 12 | 5 | 1 |
|
| |
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 200 mL, 32 (KetoCal 4:1 LQ) | Oral |
| KetoCal 4:1 LQ | SB | MP NP | C4709 |
| 5 | 5 | 1 |
|
|
Oral semi-solid 100 g, 48 (Keyo) | Oral |
| Keyo | VF | MP NP | C6858 |
| 3 | 5 | 1 |
|
| |
Oral powder 300 g (KetoCal 3:1) | Oral |
| KetoCal 3:1 | SB | MP NP | C4253 |
| 24 | 5 | 1 |
|
| |
Oral powder 300 g (KetoCal 4:1) | Oral |
| KetoCal 4:1 | SB | MP NP | C4289 |
| 24 | 5 | 1 |
|
| |
Human menopausal gonadotrophin | Powder for injection 600 I.U. with solvent | Injection |
| Menopur 600 | FP | MP | C5027 |
| 3 | 0 | 1 |
| D(100) |
Powder for injection 1,200 I.U. with solvent | Injection |
| Menopur 1200 | FP | MP | C5027 |
| 4 | 0 | 1 |
| D(100) | |
Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | Application to the eye |
| Hylo-Fresh | AE | MP NP AO | C4105 |
| 1 | 5 | 1 |
|
|
Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | Application to the eye |
| Hylo-Forte | AE | AO MP NP | C4105 |
| 1 | 5 | 1 |
|
| |
Hydralazine | Tablet containing hydralazine hydrochloride 25 mg | Oral |
| Alphapress 25 | AF | MP NP |
|
| 200 | 2 | 100 |
|
|
Tablet containing hydralazine hydrochloride 50 mg | Oral |
| Alphapress 50 | AF | MP NP |
|
| 200 | 2 | 100 |
|
| |
Hydrochlorothiazide | Tablet 25 mg | Oral |
| Dithiazide | FF | MP NP |
|
| 100 | 1 | 100 |
|
|
Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
| Moduretic | AS | MP NP |
|
| 100 | 1 | 50 |
|
|
Hydrochlorothiazide with triamterene | Tablet 25 mg-50 mg | Oral |
| Hydrene 25/50 | AF | MP NP |
|
| 100 | 1 | 100 |
|
|
Hydrocortisone | Tablet 4 mg | Oral | a | Hydrocortisone Mylan 4 | AL | MP NP |
|
| 50 | 4 | 50 |
|
|
a | Hysone 4 | AF | MP NP |
|
| 50 | 4 | 50 |
|
| |||
Tablet 20 mg | Oral | a | Hydrocortisone Mylan 20 | AL | MP NP |
|
| 60 | 4 | 60 |
|
| |
a | Hysone 20 | AF | MP NP |
|
| 60 | 4 | 60 |
|
| |||
Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection |
| Solu-Cortef | PF | MP NP |
|
| 2 | 0 | 1 |
|
| |
MP NP PDP |
| P6252 | 6 | 0 | 1 |
|
| ||||||
Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection |
| Solu-Cortef | PF | MP NP |
|
| 1 | 0 | 1 |
|
| |
MP NP PDP |
| P6252 | 6 | 0 | 1 |
|
| ||||||
Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | a | Cortic-DS 1% | FM | PDP | C4934 |
| 1 | 0 | 1 |
|
| |
a | Sigmacort | QA | PDP | C4934 |
| 1 | 0 | 1 |
|
| |||
a | Cortic-DS 1% | FM | MP NP | C4899 |
| 1 | 1 | 1 |
|
| |||
a | Sigmacort | QA | MP NP | C4899 |
| 1 | 1 | 1 |
|
| |||
Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g | Rectal |
| Colifoam | GO | MP NP | C4872 C4893 |
| 2 | 3 | 1 |
|
| |
Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye |
| Hycor | QA | MP NP AO |
|
| 1 | 0 | 1 |
|
| |
Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | a | Cortic-DS 1% | FM | PDP | C4934 |
| 1 | 0 | 1 |
|
| |
a | Sigmacort | QA | PDP | C4934 |
| 1 | 0 | 1 |
|
| |||
a | Cortic-DS 1% | FM | MP NP | C4899 |
| 1 | 1 | 1 |
|
| |||
a | Sigmacort | QA | MP NP | C4899 |
| 1 | 1 | 1 |
|
| |||
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection |
| Dilaudid | MF | MP NP |
|
| 5 | 0 | 5 |
|
|
Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection |
| Dilaudid-HP | MF | MP NP |
|
| 5 | 0 | 5 |
|
| |
Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL | Oral |
| Dilaudid | MF | PDP | C4926 |
| 1 | 0 | 1 |
|
| |
MP NP | C4959 |
| 1 | 0 | 1 |
|
| ||||||
Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL | Oral |
| Dilaudid | MF | PDP | C4926 |
| 1 | 0 | 1 |
|
| |
MP NP | C4959 |
| 1 | 0 | 1 |
|
| ||||||
Tablet containing hydromorphone hydrochloride 2 mg | Oral |
| Dilaudid | MF | PDP | C4926 |
| 20 | 0 | 20 |
|
| |
MP NP | C4959 |
| 20 | 0 | 20 |
|
| ||||||
Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral |
| Jurnista | JC | MP NP | C4556 |
| 14 | 0 | 14 |
|
| |
Tablet containing hydromorphone hydrochloride 4 mg | Oral |
| Dilaudid | MF | PDP | C4926 |
| 20 | 0 | 20 |
|
| |
MP NP | C4959 |
| 20 | 0 | 20 |
|
| ||||||
Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral |
| Jurnista | JC | MP NP | C4556 |
| 14 | 0 | 14 |
|
| |
Tablet containing hydromorphone hydrochloride 8 mg | Oral |
| Dilaudid | MF | PDP | C4926 |
| 20 | 0 | 20 |
|
| |
MP NP | C4959 |
| 20 | 0 | 20 |
|
| ||||||
Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral |
| Jurnista | JC | MP NP | C4556 |
| 14 | 0 | 14 |
|
| |
Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral |
| Jurnista | JC | MP NP | C4556 |
| 14 | 0 | 14 |
|
| |
Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral |
| Jurnista | JC | MP NP | C4556 |
| 14 | 0 | 14 |
|
| |
Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection |
| Cobal-B12 | JU | MP NP | C5840 C5841 C5854 |
| 3 | 0 | 3 |
|
|
| Vita-B12 | GH | MP NP | C5840 C5841 C5854 |
| 3 | 0 | 3 |
|
| |||
Injection 1 mg (as chloride) in 1 mL | Injection |
| Hydroxo-B12 | AS | MP NP | C5840 C5841 C5854 |
| 3 | 0 | 3 |
|
| |
| Neo-B12 | PF | MP NP | C5840 C5841 C5854 |
| 3 | 0 | 3 |
|
| |||
Hydroxycarbamide | Capsule 500 mg | Oral |
| Hydrea | BQ | MP |
|
| 100 | 3 | 100 |
|
|
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | a | APO- Hydroxychloroquine | TX | MP NP |
|
| 100 | 1 | 100 |
|
|
a | Hequinel | RW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Hydroxychloroquine AN | EA | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Hydroxychloroquine GH | GQ | MP NP |
|
| 100 | 1 | 100 |
|
| |||
a | Plaquenil | SW | MP NP |
|
| 100 | 1 | 100 |
|
| |||
Hydroxyethyl starch 130/0.4 | I.V. infusion 30 g per 500 mL, 500 mL | Injection |
| Voluven 6% | PK | MP NP |
|
| 3 | 0 | 1 |
|
|
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | a | Buscopan | VZ | MP NP | C6207 |
| 30 | 3 | 5 |
|
|
a | HYOSCINE BUTYLBROMIDE SXP | XC | MP NP | C6207 |
| 30 | 3 | 5 |
|
| |||
Hypromellose | Eye drops 3 mg per mL, 10 mL | Application to the eye | a | Genteal | AQ | AO | C6120 |
| 1 | 5 | 1 |
|
|
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | In a Wink Moisturising | IQ | AO | C6120 |
| 1 | 5 | 1 |
|
| |||
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | Genteal | AQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
a | In a Wink Moisturising | IQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
Eye drops 3 mg per mL, 15 mL | Application to the eye | a | Genteal | AQ | AO | C6120 |
| 1 | 5 | 1 |
|
| |
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | In a Wink Moisturising | IQ | AO | C6120 |
| 1 | 5 | 1 |
|
| |||
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | Genteal | AQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
a | In a Wink Moisturising | IQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
Eye drops 5 mg per mL, 15 mL | Application to the eye |
| Methopt | QA | MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| |
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
AO | C6120 |
| 1 | 5 | 1 |
|
| ||||||
MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| ||||||
Hypromellose with carbomer 980 | Ocular lubricating gel 3 mg-2 mg per g, 10 g | Application to the eye | a | Genteal gel | AQ | AO | C6120 |
| 1 | 5 | 1 |
|
|
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | HPMC PAA | IQ | AO | C6120 |
| 1 | 5 | 1 |
|
| |||
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
a | Genteal gel | AQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
a | HPMC PAA | IQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 | Application to the eye |
| Bion Tears | AQ | AO MP NP | C6172 |
| 3 | 5 | 1 |
|
|
Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | a | Poly-Tears | IQ | MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| |
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
AO | C6120 |
| 1 | 5 | 1 |
|
| ||||||
a | Tears Naturale | AQ | MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| |||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
AO | C6120 |
| 1 | 5 | 1 |
|
| ||||||
a | Poly-Tears | IQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
a | Tears Naturale | AQ | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
Ibandronic acid | Concentrated injection for I.V. infusion 6 mg (as ibandronate sodium monohydrate) in 6 mL | Injection |
| Bondronat | IX | MP | C5257 C5291 |
| 1 | 11 | 1 |
| PB(100) |
Tablet 50 mg (as ibandronate sodium monohydrate) | Oral |
| Bondronat | IX | MP NP | C4922 |
| 28 | 2 | 28 |
|
| |
Ibrutinib | Capsule 140 mg | Oral |
| Imbruvica | JC | MP | C7806 C7818 C7858 C7865 C7871 | P7858 P7871 | 90 | 5 | 90 |
|
|
|
|
|
|
|
| MP | C7806 C7818 C7858 C7865 C7871 | P7806 P7818 P7865 | 120 | 5 | 120 |
|
|
Ibuprofen | Tablet 400 mg | Oral | a | APO-Ibuprofen 400 | TX | MP NP MW PDP |
|
| 30 | 0 | 30 |
|
|
a | Brufen | GO | MP NP MW PDP |
|
| 30 | 0 | 30 |
|
| |||
a | APO-Ibuprofen 400 | TX | PDP |
| P6256 P6282 | 90 | 0 | 30 |
|
| |||
a | Brufen | GO | PDP |
| P6256 P6282 | 90 | 0 | 30 |
|
| |||
a | APO-Ibuprofen 400 | TX | MP NP |
| P6149 P6214 P6283 | 90 | 3 | 30 |
|
| |||
a | Brufen | GO | MP NP |
| P6149 P6214 P6283 | 90 | 3 | 30 |
|
| |||
Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection |
| Firazyr | ZI | MP | C7273 C7274 |
| 1 | 1 | 1 |
|
|
Idarubicin | Capsule containing idarubicin hydrochloride 5 mg | Oral |
| Zavedos | PF | MP | C5812 |
| 3 | 0 | 1 |
|
|
Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL | Injection |
| Zavedos Solution | PF | MP | C6247 |
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
Solution for I.V. injection containing idarubicin hydrochloride 10 mg in 10 mL | Injection |
| Idarubicin Ebewe | SZ | MP | C6247 |
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
| Zavedos Solution | PF | MP | C6247 |
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
Idelalisib | Tablet 100 mg | Oral |
| Zydelig | GI | MP | C7052 C7053 C7387 C7388 |
| 60 | 5 | 60 |
|
|
Tablet 150 mg | Oral |
| Zydelig | GI | MP | C7052 C7053 C7387 C7388 |
| 60 | 5 | 60 |
|
| |
Ifosfamide | Powder for I.V. injection 1 g | Injection |
| Holoxan | BX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
Powder for I.V. injection 2 g | Injection |
| Holoxan | BX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Iloprost | Solution for inhalation 20 micrograms (as trometamol) in 2 mL | Inhalation |
| Ventavis | BN | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 30 |
| D(100) |
Imatinib | Capsule 100 mg (as mesilate) | Oral |
| CIPLA IMATINIB ADULT | LR | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
|
| Glivanib | JU | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| IMATINIB AN | JO | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| Imatinib GH | GQ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| Imatinib-APOTEX | TX | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| IMATINIB-DRLA | RZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| CIPLA IMATINIB ADULT | LR | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| Glivanib | JU | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| IMATINIB AN | JO | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| Imatinib GH | GQ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| Imatinib-APOTEX | TX | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| IMATINIB-DRLA | RZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
Capsule 400 mg (as mesilate) | Oral |
| CIPLA IMATINIB ADULT | LR | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |
| Glivanib | JU | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| IMATINIB AN | JO | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| Imatinib GH | GQ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| Imatinib-APOTEX | TX | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| IMATINIB-DRLA | RZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| CIPLA IMATINIB ADULT | LR | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| Glivanib | JU | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| IMATINIB AN | JO | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| Imatinib GH | GQ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| Imatinib-APOTEX | TX | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| IMATINIB-DRLA | RZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
Tablet 100 mg (as mesilate) | Oral |
| Glivec | AF | MP | C4342 C4355 C6496 C6498 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6559 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6498 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6559 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |
| IMATINIB RBX | RA | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 60 | 2 | 60 |
|
| |||
| Imatinib-Teva | SZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6550 P6557 P6896 P6942 P7884 P8697 | 60 | 2 | 60 |
|
| |||
| Glivec | AF | MP | C4342 C4355 C6496 C6498 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6559 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P4342 P4355 P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| IMATINIB RBX | RA | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
| Imatinib-Teva | SZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 | P6948 P6949 P6973 | 60 | 5 | 60 |
|
| |||
Tablet 400 mg (as mesilate) | Oral |
| Glivec | AF | MP | C4342 C4355 C6496 C6498 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6559 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6498 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6559 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |
| IMATINIB RBX | RA | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6540 P6550 P6557 P6896 P6942 P7884 P8697 P8698 | 30 | 2 | 30 |
|
| |||
| Imatinib-Teva | SZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 | P6496 P6499 P6510 P6526 P6527 P6538 P6539 P6550 P6557 P6896 P6942 P7884 P8697 | 30 | 2 | 30 |
|
| |||
| Glivec | AF | MP | C4342 C4355 C6496 C6498 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6559 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P4342 P4355 P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| IMATINIB RBX | RA | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6540 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 C8698 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
| Imatinib-Teva | SZ | MP | C6496 C6499 C6510 C6526 C6527 C6538 C6539 C6550 C6557 C6896 C6942 C6948 C6949 C6973 C7884 C8697 | P6948 P6949 P6973 | 30 | 5 | 30 |
|
| |||
Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral |
| Tofranil 10 | GH | MP NP |
|
| 50 | 2 | 50 |
|
|
Tablet containing imipramine hydrochloride 25 mg | Oral |
| Tofranil 25 | GH | MP NP |
|
| 50 | 2 | 50 |
|
| |
Imiquimod | Cream 50 mg per g, 2 g, 2 | Application |
| Aldara Pump | IL | MP | C4229 |
| 1 | 1 | 1 |
|
|
Cream 50 mg per g, 250 mg single use sachets, 12 | Application |
| Aldara | IL | MP | C4229 |
| 1 | 1 | 1 |
|
| |
| Aldiq | QA | MP | C4229 |
| 1 | 1 | 1 |
|
| |||
| APO-Imiquimod | TX | MP | C4229 |
| 1 | 1 | 1 |
|
| |||
IncobotulinumtoxinA | Lyophilised powder for injection 100 units | Injection |
| Xeomin | EZ | MP | C5220 C5222 C5360 |
| 4 | 0 | 1 |
| D(100) |
Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
| Onbrez | NV | MP NP | C6366 |
| 30 | 5 | 30 |
|
|
Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
| Onbrez | NV | MP NP | C6366 |
| 30 | 5 | 30 |
|
| |
Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
| ultibro breezhaler 110/50 | NV | MP NP | C7798 |
| 30 | 5 | 30 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | a | APO-Indapamide SR | TX | MP NP |
|
| 90 | 1 | 90 |
|
|
a | Chem mart Indapamide SR | CH | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | INDAPAMIDE AN SR | EA | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Natrilix SR | SE | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Odaplix SR | AF | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Tenaxil SR | RW | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Terry White Chemists Indapamide SR | TW | MP NP |
|
| 90 | 1 | 90 |
|
| |||
Tablet containing indapamide hemihydrate 2.5 mg | Oral | a | Dapa-Tabs | AF | MP NP |
|
| 90 | 1 | 90 |
|
| |
a | GenRx Indapamide | GX | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Indapamide AN | EA | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Indapamide Sandoz | SZ | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Insig | RW | MP NP |
|
| 90 | 1 | 90 |
|
| |||
a | Natrilix | SE | MP NP |
|
| 90 | 1 | 90 |
|
| |||
Indometacin | Capsule 25 mg | Oral | a | Arthrexin | AF | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
|
a | Indocid | AS | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Arthrexin | AF | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Indocid | AS | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
Suppository 100 mg | Rectal |
| Indocid | AS | PDP |
|
| 40 | 0 | 20 |
|
| |
MP NP |
|
| 40 | 3 | 20 |
|
| ||||||
MP NP |
| P6149 | 40 | 3 | 20 |
|
| ||||||
Infliximab | Powder for I.V. infusion 100 mg | Injection |
| Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
| Remicade | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Renflexis | MK | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |||
Insect allergen extract-honey bee venom | Injection set containing 550 micrograms | Injection |
| Albey Bee Venom | DE | MP |
|
| 1 | 0 | 1 |
|
|
Injection set containing 550 micrograms with diluent | Injection |
| Hymenoptera Honey Bee Venom | DE | MP |
|
| 1 | 0 | 1 |
|
| |
Insect allergen extract-paper wasp venom | Injection set containing 550 micrograms | Injection |
| Albey Paper Wasp Venom | DE | MP |
|
| 1 | 0 | 1 |
|
|
| Injection set containing 550 micrograms with diluent | Injection |
| Hymenoptera Paper Wasp Venom | DE | MP |
|
| 1 | 0 | 1 |
|
|
Insect allergen extract-yellow jacket venom | Injection set containing 550 micrograms | Injection |
| Albey Yellow Jacket Venom | DE | MP |
|
| 1 | 0 | 1 |
|
|
| Injection set containing 550 micrograms with diluent | Injection |
| Hymenoptera Yellow Jacket Venom | DE | MP |
|
| 1 | 0 | 1 |
|
|
Insulin aspart | Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| NovoRapid | NO | MP NP |
|
| 5 | 2 | 1 |
|
|
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| NovoRapid FlexPen | NF | MP NP |
|
| 5 | 1 | 1 |
|
| |
| NovoRapid Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection |
| NovoMix 30 FlexPen | NF | MP NP |
|
| 5 | 1 | 1 |
|
|
| NovoMix 30 Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Insulin degludec with insulin aspart | Injections, cartridges, 70 units-30 units per mL, 3 mL, 5 | Injection |
| Ryzodeg Penfill | NO | MP NP |
|
| 5 | 1 | 1 |
|
|
| Injections, pre-filled pen, 70 units-30 units per mL, 3 mL, 5 | Injection |
| Ryzodeg Flextouch | NO | MP NP |
|
| 5 | 1 | 1 |
|
|
Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Levemir FlexPen | NF | MP NP | C5174 |
| 5 | 1 | 1 |
|
|
| Levemir Penfill | NO | MP NP | C5174 |
| 5 | 1 | 1 |
|
| |||
Insulin glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Lantus | SW | MP NP |
|
| 5 | 1 | 1 |
|
|
| Lantus SoloStar | AV | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
| Toujeo Solostar | SW | MP NP |
|
| 5 | 1 | 1 |
|
| |
Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
| Toujeo Solostar | SW | MP NP |
|
| 5 | 1 | 1 |
|
| |
Insulin glulisine | Injection (human analogue) 100 units per mL, 10 mL | Injection |
| Apidra | SW | MP NP |
|
| 5 | 2 | 1 |
|
|
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Apidra | AV | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Apidra SoloStar | SW | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Insulin isophane | Injection (human) 100 units per mL, 10 mL | Injection |
| Humulin NPH | LY | MP NP |
|
| 5 | 2 | 1 |
|
|
| Protaphane | NO | MP NP |
|
| 5 | 2 | 1 |
|
| |||
Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Humulin NPH | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Protaphane InnoLet | NI | MP NP |
|
| 5 | 1 | 1 |
|
| |||
| Protaphane Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injection (bovine) 100 units per mL, 10 mL | Injection |
| Hypurin Isophane | AS | MP NP | C4332 |
| 5 | 2 | 1 |
|
| |
Insulin lispro | Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| Humalog | LY | MP NP |
|
| 5 | 2 | 1 |
|
|
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Humalog | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Humalog KwikPen | KP | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injections (human analogue), pre-filled pen, 200 units per mL, 3 mL, 5 | Injection |
| Humalog U200 Kwikpen | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 | Injection |
| Humalog Mix25 | LY | MP NP |
|
| 5 | 1 | 1 |
|
|
| Humalog Mix25 KwikPen | KP | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection |
| Humalog Mix50 | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Humalog Mix50 KwikPen | KP | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Insulin neutral | Injection (human) 100 units per mL, 10 mL | Injection |
| Actrapid | NO | MP NP |
|
| 5 | 2 | 1 |
|
|
| Humulin R | LY | MP NP |
|
| 5 | 2 | 1 |
|
| |||
Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Actrapid Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Humulin R | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injection (bovine) 100 units per mL, 10 mL | Injection |
| Hypurin Neutral | AS | MP NP | C4332 |
| 5 | 2 | 1 |
|
| |
Insulin neutral with insulin isophane | Injection (human) 30 units-70 units per mL, 10 mL | Injection |
| Humulin 30/70 | LY | MP NP |
|
| 5 | 2 | 1 |
|
|
Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection |
| Humulin 30/70 | LY | MP NP |
|
| 5 | 1 | 1 |
|
| |
| Mixtard 30/70 InnoLet | NI | MP NP |
|
| 5 | 1 | 1 |
|
| |||
| Mixtard 30/70 Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |||
Injections (human), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection |
| Mixtard 50/50 Penfill 3 mL | NO | MP NP |
|
| 5 | 1 | 1 |
|
| |
Interferon alfa-2a | Injection 3,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection |
| Roferon-A | RO | MP | C6632 C6648 C6672 | P6648 P6672 | 15 | 4 | 1 |
|
|
MP | C4993 C5003 C5036 C5042 C6661 C6662 C6678 | P6662 P6678 | 15 | 4 | 1 |
| C(100) | ||||||
MP | C6632 C6648 C6672 | P6632 | 15 | 5 | 1 |
|
| ||||||
MP | C4993 C5003 C5036 C5042 C6661 C6662 C6678 | P6661 | 15 | 5 | 1 |
| C(100) | ||||||
MP | C4993 C5003 C5036 C5042 C6661 C6662 C6678 | P4993 P5003 P5036 P5042 | 30 | 5 | 1 |
| C(100) | ||||||
Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection |
| Roferon-A | RO | MP | C6632 C6672 | P6672 | 5 | 4 | 1 |
|
| |
MP | C4993 C5003 C5036 C5042 C6661 C6678 | P6678 | 5 | 4 | 1 |
| C(100) | ||||||
MP | C6632 C6672 | P6632 | 5 | 5 | 1 |
|
| ||||||
MP | C4993 C5003 C5036 C5042 C6661 C6678 | P6661 | 5 | 5 | 1 |
| C(100) | ||||||
MP | C4993 C5003 C5036 C5042 C6661 C6678 | P4993 P5003 P5036 P5042 | 30 | 5 | 1 |
| C(100) | ||||||
Interferon beta-1a | Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection |
| Avonex | BD | MP | C6860 C7695 |
| 4 | 5 | 4 |
|
|
Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose autoinjector | Injection |
| Rebif 44 | SG | MP | C6860 C7695 |
| 12 | 5 | 12 |
|
| |
Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection |
| Rebif 44 | SG | MP | C6860 C7695 |
| 12 | 5 | 12 |
|
| |
Solution for injection 132 micrograms in 1.5 mL multidose cartridge | Injection |
| Rebif 44 | SG | MP | C6860 C7695 |
| 4 | 5 | 4 |
|
| |
Interferon beta-1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection |
| Betaferon | BN | MP | C6860 C7695 |
| 15 | 5 | 15 |
|
|
Interferon gamma-1b | Injection 2,000,000 I.U. in 0.5 mL | Injection |
| Imukin | EU | MP | C6222 C6286 |
| 12 | 11 | 6 |
| D(100) |
Ipilimumab | Injection concentrate for I.V. infusion 50 mg in 10 mL | Injection |
| Yervoy | BQ | MP | C6562 C6585 C8142 C8178 C8180 C8206 C8555 C8569 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Injection concentrate for I.V. infusion 200 mg in 40 mL | Injection |
| Yervoy | BQ | MP | C6562 C6585 C8142 C8178 C8180 C8206 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Ipratropium | Pressurised inhalation containing ipratropium bromide monohydrate 21 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth |
| Atrovent | BY | MP NP |
|
| 2 | 5 | 1 |
|
|
Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | a | Aeron 250 | QA | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |
a | APO-Ipratropium | TX | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
a | Atrovent | BY | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
a | Ipratrin | AF | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | a | Aeron 500 | QA | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |
a | APO-Ipratropium | TX | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
a | Atrovent Adult | BY | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
a | Ipratrin Adult | AF | MP NP | C6331 C6341 |
| 2 | 5 | 1 |
|
| |||
Irbesartan | Tablet 75 mg | Oral | a | Abisart | AF | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Abisart 75 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Avapro | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Actavis 75 | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AMNEAL | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan GH | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irprestan 75 | ZP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Karvea | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 150 mg | Oral | a | Abisart | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Abisart 150 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Avapro | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Actavis 150 | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AMNEAL | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan GH | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irprestan 150 | ZP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Karvea | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 300 mg | Oral | a | Abisart | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Abisart 300 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Avapro | AV | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Actavis 300 | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AMNEAL | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan GH | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Irprestan 300 | ZP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Karvea | SW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | a | Abisart HCT 150/12.5 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
|
a | Abisart HCTZ 150/12.5 | AL | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan HCTZ | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Avapro HCT 150/12.5 | AV | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN HCT 150/12.5 | RF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan HCTZ 150/12.5 | IB | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan HCTZ | CH | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT Actavis 150/12.5 | ED | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT GH 150/12.5 | GQ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCTZ AMNEAL | EF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Karvezide 150/12.5 | SW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | KSART HCT 150/12.5 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan HCTZ | TW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Tablet 300 mg-12.5 mg | Oral | a | Abisart HCT 300/12.5 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |
a | Abisart HCTZ 300/12.5 | AL | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan HCTZ | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Avapro HCT 300/12.5 | AV | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN HCT 300/12.5 | RF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan HCTZ 300/12.5 | IB | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan HCTZ | CH | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT Actavis 300/12.5 | ED | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT GH 300/12.5 | GQ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCTZ AMNEAL | EF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Karvezide 300/12.5 | SW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | KSART HCT 300/12.5 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan HCTZ | TW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Tablet 300 mg-25 mg | Oral | a | Abisart HCT 300/25 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |
a | Abisart HCTZ 300/25 | AL | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | APO-Irbesartan HCTZ | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Avapro HCT 300/25 | AV | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | AVSARTAN HCT 300/25 | RF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Blooms the Chemist Irbesartan HCTZ 300/25 | IB | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Irbesartan HCTZ | CH | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT Actavis 300/25 | ED | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCT GH 300/25 | GQ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan HCTZ AMNEAL | EF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Karvezide 300/25 | SW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | KSART HCT 300/25 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Irbesartan HCTZ | TW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection |
| MEDITAB IRINOTECAN | LR | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
| Omegapharm Irinotecan | OE | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection |
| Hospira Pty Limited | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Irinotecan Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| IRINOTECAN ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Irinotecan Alphapharm | AF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Irinotecan Kabi | PK | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| MEDITAB IRINOTECAN | LR | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Omegapharm Irinotecan | OE | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection |
| Hospira Pty Limited | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| IRINOTECAN ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Irinotecan Alphapharm | AF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection |
| Ferrosig | SI | MP NP |
|
| 5 | 0 | 5 |
|
|
MP NP |
| P4302 | 5 | 5 | 5 |
|
| ||||||
Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection |
| Venofer | VL | MP NP |
|
| 5 | 0 | 5 |
|
|
MP NP |
| P4302 | 5 | 5 | 5 |
|
| ||||||
Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000) | Oral |
| Isoleucine 1000 | VF | MP NP | C5571 |
| 4 | 5 | 1 |
|
|
Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50) | Oral |
| Isoleucine 50 | VF | MP NP | C5571 |
| 4 | 5 | 1 |
|
| |
Isoniazid | Tablet 100 mg | Oral |
| Arrow Pharma Pty Ltd | RW | MP NP |
|
| 100 | 2 | 100 |
|
|
Isosorbide dinitrate | Tablet 5 mg (sublingual) | Oral |
| Isordil Sublingual | RW | MP NP |
|
| 200 | 2 | 100 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | a | Chem mart Isosorbide Mononitrate | CH | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Duride | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | GenRx Isosorbide Mononitrate | GX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Imdur Durule | IX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Isomonit | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Isosorbide AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Monodur 60 mg | IY | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Isosorbide Mononitrate | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 120 mg (sustained release) | Oral | a | Imdur 120 mg | IX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Monodur 120 mg | IY | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Isotretinoin | Capsule 10 mg | Oral | a | APO-Isotretinoin | TX | MP | C5224 |
| 60 | 3 | 60 |
|
|
a | Dermatane | ER | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Isotretinoin AN | EA | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Oratane | RF | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Rocta 10 | RW | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
Capsule 20 mg | Oral | a | Roaccutane | RO | MP | C5224 |
| 60 | 3 | 30 |
|
| |
|
|
| MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | APO-Isotretinoin | TX | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Dermatane | ER | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Isotretinoin AN | EA | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Isotretinoin SCP 20 | CR | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
a | Oratane | RF | MP | C5224 |
| 60 | 3 | 60 |
|
| |||
|
| a | Rocta 20 | RW | MP | C5224 |
| 60 | 3 | 60 |
|
| |
Capsule 40 mg | Oral | a | Dermatane | ER | MP | C5224 |
| 30 | 3 | 30 |
|
| |
a | Oratane | RF | MP | C5224 |
| 30 | 3 | 30 |
|
| |||
Itraconazole | Capsule 50 mg | Oral |
| Lozanoc | YN | MP NP | C5988 C6005 C6016 C6022 C6035 C6037 C6057 |
| 60 | 5 | 60 |
|
|
Capsule 100 mg | Oral | a | APO-Itraconazole | TX | MP NP | C5988 C6005 C6016 C6022 C6035 C6037 C6057 |
| 60 | 5 | 60 |
|
| |
a | Itracap | AF | MP NP | C5988 C6005 C6016 C6022 C6035 C6037 C6057 |
| 60 | 5 | 60 |
|
| |||
a | ITRANOX | RW | MP NP | C5988 C6005 C6016 C6022 C6035 C6037 C6057 |
| 60 | 5 | 60 |
|
| |||
a | Sporanox | JC | MP NP | C5988 C6005 C6016 C6022 C6035 C6037 C6057 |
| 60 | 5 | 60 |
|
| |||
Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | a | APO-Ivabradine | TX | MP NP | C4979 |
| 56 | 5 | 56 |
|
|
|
| a | Coralan | SE | MP NP | C4979 |
| 56 | 5 | 56 |
|
| |
Tablet 7.5 mg (as hydrochloride) | Oral | a | APO-Ivabradine | TX | MP NP | C4979 |
| 56 | 5 | 56 |
|
| |
|
|
| a | Coralan | SE | MP NP | C4979 |
| 56 | 5 | 56 |
|
|
Ivacaftor | Sachet containing granules 50 mg | Oral |
| Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 56 |
| D(100) |
Sachet containing granules 75 mg | Oral |
| Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 56 |
| D(100) | |
Tablet 150 mg | Oral |
| Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 56 |
| D(100) | |
Ivermectin | Tablet 3 mg | Oral |
| Stromectol | MK | MP NP | C4319 C4328 C4565 C4566 | P4319 | 4 | 0 | 4 |
|
|
MP NP | C4319 C4328 C4565 C4566 | P4328 P4565 P4566 | 8 | 2 | 4 |
|
| ||||||
Ixekizumab | Injection 80 mg in 1 mL single dose pre-filled pen | Injection |
| Taltz | LY | MP | C6695 C6726 C6727 C6728 C6753 C6755 C6756 C8562 C8583 C8591 C8592 C8602 C8612 | P6755 P6756 P8562 P8583 P8591 P8592 P8602 P8612 | 2 | 2 | 2 |
|
|
MP | C6695 C6726 C6727 C6728 C6753 C6755 C6756 C8562 C8583 C8591 C8592 C8602 C8612 | P6695 P6726 P6727 P6728 P6753 | 2 | 3 | 2 |
|
| ||||||
Ketoconazole | Cream 20 mg per g, 30 g | Application |
| Nizoral 2% Cream | JT | MP NP | C6434 |
| 1 | 2 | 1 |
|
|
Shampoo 10 mg per g, 100 mL | Application |
| Nizoral 1% | JT | MP NP | C6434 |
| 1 | 1 | 1 |
|
| |
Shampoo 20 mg per g, 60 mL | Application |
| Nizoral 2% | JT | MP NP | C6434 |
| 1 | 1 | 1 |
|
| |
Ketoprofen | Capsule 200 mg (sustained release) | Oral | a | Orudis SR 200 | SW | PDP | C6214 |
| 28 | 0 | 28 |
|
|
a | Oruvail SR | AV | PDP | C6214 |
| 28 | 0 | 28 |
|
| |||
a | Orudis SR 200 | SW | MP NP | C6214 |
| 28 | 3 | 28 |
|
| |||
a | Oruvail SR | AV | MP NP | C6214 |
| 28 | 3 | 28 |
|
|